D. Allan Butterfield | ��vlog�ٷ�� College of Arts & Sciences

D. Allan Butterfield

The Alumni Association Endowed Professor of Biological ��vlog�ٷ��, 249 Chem-Phys, 859-257-3184

Director, Redox Metabolism Shared Resource Facility, Markey Cancer Center, 225 HSRB, 859-323-0476

Faculty, Sanders-Brown Center on Aging

Faculty Associate, Spinal Cord and Brain Injury Research Center

Associate Vice President for Research

Contact Information

dabcns@uky.edu

249 ��vlog�ٷ��-Physics Building

859-257-3184 (office)

859-323-9985 (fax)

Education

Ph.D. Duke University, 1974
NIH Postdoctoral Fellow, Neuroscience, Duke University School of Medicine, 1974-1975

Affiliations

Biological
��vlog�ٷ��
Neuroscience

Curriculum Vitae (CV)

Graduate Training

Biophysical ��vlog�ٷ�� and Neurochemistry

Research

The Butterfield laboratory studies free radical oxidative stress in aging and age-related neurodegenerative disorders, particularly Alzheimer's disease (AD). We discovered in AD brain that such oxidative stress is manifested by protein oxidation, lipid peroxidation, reactive oxygen species (ROS) production, mitochondrial dysfunction, and functional impairment of key transmembrane transport proteins, among many others. Our laboratory studies these and other aspects of oxidative stress in brain membranes using a variety of techniques, including immunochemical, metabolomic, and proteomics methods. Our group first described how oxidative stress associated with amyloid β-peptide, a 42-amino acid peptide deposited in AD brains, leads to neurotoxicity and how various antioxidants can modulate or prevent this oxidative stress and neuronal death. Insight into the molecular basis for and potential therapeutic interventions in aging and age-related neurodegenerative disorders is envisaged from our research. Recent research has emphasized the close connection between Type 2 diabetes mellitus and development of AD. We found that brain from subjects with AD and for the first time in arguably AD’s earlier form, Mild Cognitive Impairment (MCI), strong evidence of insulin resistance, which contributes to the metabolic changes in brain well known in AD.

Our laboratory pioneered the techniques of redox proteomics (see figure below) to identify oxidatively modified brain proteins in subjects with AD and MCI. Proteins identified have provided new insights into molecular processes involved in mechanisms of neuronal death in and progression of AD.

Processes involved in redox proteomics, which is used to identify oxidatively modified brain proteins in Alzheimer's disease and other neurodegenerative disorders.

In a second area of research, the Butterfield laboratory discovered a mechanism for chemotherapy induced cognitive impairment (CICI), which lowers the quality of life for up to 70 percent of the currently 14 million cancer survivors in the USA. Diminished executive functioning, inability to multitask, and slowness in mental processing, called “chemobrain” by patients, often are complaints described by persons with CICI. Metabolic analyses using Seahorse technology and MS-based methods suggest mitochondrial dysfunction and apoptosis in brain following chemotherapy involving ROS associated chemotherapeutic agents, even though these agents do not cross the blood-brain barrier. We found an important inflammatory cytokine is elevated in plasma, and this harmful molecule does cross the BBB to initiate a series of harmful biochemical processes in brain. Highly innovative studies using a variety of biochemical and chemical techniques are shedding light on how to prevent CICI, with the strong possibility that the quality of life of cancer survivors will be enhanced.

Publications

658. D.A. Butterfield, M. Bing, Q. Peng, S. Hardas, J. Unrine, E. Grulke, U. Graham, M. Tseng, J. Cai, J.B. Klein, D. Pears, R.A. Yokel, and R. Sultana, “Identification of Serum or Plasma Proteins Bound to Nanoceria Using a Proteomics Approach: Insights into Potential Pathways by which Ceria NPs May Exert Beneficial or Deleterious Effects in vivo,” Manuscript in Preparation (2018).

657. X. Ren, J. Keeney, S. Miriyala, T. Noel, D. Powell, S. Bondada, D. St. Clair, and D.A. Butterfield, “The Triangle of Death of Neurons, Oxidative Damage, Mitochondrial Dysfunction, and Loss of Choline-Containing Biomolecules, in Brains of Mice Treated with Doxorubicin: Advanced Insights into Mechanisms of Chemotherapy Induced Cognitive Impairment (“Chemobrain”) Involving TNF-alpha,” Submitted for Publication (2018).

656. A. Tramutola, G. Abate, C. Lanzillotta, F. Triani, E. Barone, F. Iavarone, F. Vincenzoni, M. Castagnola, M. Marziano, M. Memo, E. Garrafa, D.A. Butterfield, M. Perluigi, F. Di Domenico, and Daniela Uberti, “Redox Proteomics Analysis of 3-NT-modified Proteins in T Cells from Alzheimer Disease Patients: Involvement in Immunosenescence and/or Pathology Prediction,” Submitted for Publication (2018).

655. A.Tramutola, C. Lanzillotta, E. Barone, A. Arena, I. Zuliani, L. Mosca, C. Blarzino, D.A. Butterfield, M. Perluigi, and F. Di Domenico, “Intranasal Rapamycin Ameliorates Alzheimer-like Cognitive Decline in a Mouse Model of Down Syndrome,” Submitted (2018).

654. D.A. Butterfield and B. Halliwell, “Oxidative Stress, Glucose Dysmetabolism and Alzheimer Disease,” Submitted (2018).

653. T. Salameh, W. Mortell, A. Logsdon, D.A. Butterfield, and W. Banks, “Disruption of the Hippocampal and Hypthalamic Blood-brain Barrier in a Diet-induced Obese Model of Type II Diabetes: Prevention and Treatment by the Mitochondrial Carbonic Anhydrase Inhibitor, Topiramate,” Submitted (2018).

652. E.N. Wilson, S. Do Carmo, M.F. Iulita, H. Hall, G.L. Austin, D.T. Jia, J.C. Malcolm, D.A. Butterfield, and C.Cuello, “Microdose Lithium NP03 Diminishes Pre-Plaque Oxidative Damage and Neuroinflammation in Alzheimer rat,” Submitted (2018).

651. L. Liu, L. Qi, T. Knifley, D. Piecoro, P. Rychahou, J. Liu, M. Mitov, C. Wang, J. Wu, H. Weiss, D.A. Butterfield, B. M. Evers, K. O’Connor, and M. Chen, “S100A4 Enhances Cellular Respiration to Promote Invasive and Metastatic Capacity of Lung Cancer Cells Through Upregulation of NDUFS2,” Submmited (2018).

650. D.A. Butterfield and D. Boyd-Kimball, “Redox Proteomics and Amyloid β-Peptide: Insights into Alzheimer Disease,” J. Neurochem., Minor Revision (2018).

649. E. Barone, A. Tramutola, F. Triani, S. Calcagnini, F. Di Domenico, C. Ripoli, S. Gaetani, C. Grassi, D.A. Butterfield, T. Cassano, and M. Perluigi, “Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease” Molecular Neurobiology, in press (2018).

648. A. Tramutola, N. Sharma, E. Barone, C. Lanzillotta, A. Castellani, F. Iavarone, F. Vincenoni, M. Castagnola, D.A. Butterfield, S. Gaetani, T. Cassano, M. Perluigi, and F. Di Domenico, “Proteomic Identification of Altered Protein O-GlcNAcylation Profile in a Triple Transgenic Mouse Model of Alzheimer’s Disease. Biochimica et Biophysica Acta—Molecular Basis of Disease 1864, 3309-3321 (2018).

647. F. Triani, A. Tramutola, F. Di Domenico, N. Sharma, D.A Butterfield, E. Head, M. Perluigi, and E. Barone, “Biliverdin Reductase-A Impairment Links Brain Insulin Resistance with Increased A Production in an Animal Model of Aging: Implications for Alzheimer Disease,” Biochimica et Biophysica Acta—Molecular Basis of Disease 1864, 3181-3194 (2018).

646. J.T.R. Keeney, X. Ren, G. Warrier, T. Noel, D.K. Powell, J.M. Brelsfoard, R. Sultana, K.E. Saatman, D.K. St. Clair, and D.A. Butterfield, “Doxorubicin-induced Elevated Oxidative Stress and Neurochemical Alterations in Brain and Cognitive Decline: Protection by MESNA and Insights into Mechanisms of Chemotherapy-induced Cognitive Impairment (“Chemobrain”),” Oncotarget 9, 30324-30339 (2018).

645. A. Tramutola, F. Triani, F. Di Domenico, E. Barone, M. Perluigi, and D.A. Butterfield, “Poly-ubiquitin Profile in Alzheimer Disease Brain,” Neurobiology of Disease 118, 129-141 (2018).

644. D.A. Butterfield, “Perspectives on Oxidative Stress in Alzheimer Disease and Predictors of Future Research Emphases,” Journal of Alzheimer’s Disease 64, S469-S479 (2018).

643. C. Yarana, D. Carroll, J. Chen, L. Chaiswing, Y. Zhao, T. Noel, M. Alstott, Y. Bae, E. Dressler, J. Moscow, D.A. Butterfield, H. Zhu, and D. St. Clair, “Extracellular Vesciles Released by Cardiomyocytes in a Doxorubicin-Induced Cardiac Injury Mouse Model Contain Protein Biomarkers of Early Cardiac Injury,” Clinical Cancer Research 24, 1644-1553 (2018).

642. D.A. Butterfield and D. Boyd-Kimball, “Oxidative Stress, Amyloid beta-Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer Disease,” Journal of Alzheimer’s Disease 62, 1345-1367 (2018).

641. F. Di Domenico, A. Tramutola, C. Foppoli, E. Head, M. Perluigi, and D.A. Butterfield, “mTOR in Down Syndrome: Role in A and Tau Neuropathology and Transition to Alzheimer Disease-like Dementia,” Free Radical Biology & Medicine 114, 94-101 (2018).

640. E. Barone, A. Arena, E. Head, D.A. Butterfield, M. Perluigi, “Disturbance of Redox Homestasis in Down Syndrome: Role of Iron Dysmetabolism,” Free Radical Biology & Medicine 114, 84-93 (2018).

639. D.A. Butterfield and M. Perluigi, “Down Syndrome: From Development to Adult Life to Alzheimer Disease,” Free Radical Biology and Medicine 114, 1-2 (2018).

638. D. Arndt, E.K. Oostveen, J. Triplett, D.A. Butterfield, O.V. Tsyusko, B.E. Collin, D.L. Starnes, J. Cai, J.B. Klein, R. Nass, and J.M. Unrine, “The Role of Charge in the Toxicity of Polymer-coated Cerium Oxide Nanomaterials to Caenorhabditis elegans,” Comp Biochem Physiol C: Toxicol Pharmacol 201, 1-10 (2017).

637. T.C. Thomas, J.A. Beitchman, F. Pomerleau, T. Noel, P. Jungsuwadee, D.A. Butterfield, D.K. St. Clair, M. Vore, G.A. Gerhardt, “Acute Treatment with Doxorubicin Affects Glutamate Neurotransmission in the Mouse Frontal Cortex and Hippocampus,” Brain Research, 1672, 10-17 (2017).

636. V. Vilchez. L. Turcios, D.A. Butterfield, M.I. Mitov, C.L. Coquillard, J.A. Brandon, V. Cornea, R. Gedaly, and F. Marti, “Evidence of the Immunomodulatory Role of Dual PI3K/mTOR Inhibitors in Transplantation: An Experimental Study in Mice,” Transplant International 30, 1061-1074 (2017).

635. J. Zhang and D.A. Butterfield, “Oxidative Stress and Neurodegeneration,” Brain Research Bullein 133, 1-3 (2017).

634. L. Turcios, V. Vilchez, L.F. Acosta, P. Poyil, D.A. Butterfield, M. Mitov, F. Marti and R. Gedaly, “Sorafenib and FH535 in Combination Act Synergistically on Hepatocellular Carcinoma by Targeting Cell Bioenergetics and Mitochondrial Function,” Digestive and Liver Disease 49, 697-704 (2017).

633. T.T. Reed and D.A. Butterfield, “Protein Carbonylation in Brains of Subjects with Selected Neurodegenerative Disorders,” in Protein Carbonylation: Principles, Analysis, and Biological Implications (J. Ros, Ed.). John Wiley & Sons, Hoboken, NJ, pp. 167-205 (2017).

632. A. Tramutola, C. Lanzillotta, M. Perluigi, and D.A. Butterfield, “Oxidative Stress, Protein Oxidation, and Alzheimer Disease,” Brain Research Bulletin 133, 88-96 (2017).

631. E. Barone, E. Head, D.A. Butterfield, and M. Perluigi, “HNE-modified Proteins in Down Syndrome: Involvement in development of Alzheimer disease neuropathology,” Free Radical Biology and Medicine 111, 262-269 (2017).

630. F. Di Domenico, A. Tramutola, and D.A. Butterfield, “Role of 4-Hydroxy-2-Nonenal (HNE) in the Pathogenesis of Alzheimer Disease and Other Selected Age-Related Neurodegenerative Disorders,” Free Radical Biology and Medicine 111, 253-261 (2017)

629. M. Mitov, J.W. Harris, M.C. Alstott, B.M. Evers, and D.A. Butterfield, “Temperature Induces Significant Changes in both Glycolytic Rerserve and Mitochondrial Spare Respiratory Capacity in Colorectal Cancer Cell Lines,” Experimental Cell Research 354, 112-121 (2017).

628. E.M. Palmieri, A. Menga, A. Lebrun, D.C. Hooper, D.A. Butterfield, M. Mazzone, and A. Castegna, “Blockade of Glutamine Synthetase Strongly Enhances Inflammatory Response in Microglial Cells,” Antioxidants and Redox Signaling 26, 351-363 (2017).

627. F. Di Domenico, E. Barone, M. Perluigi 1 and D.A.Butterfield, “The Triangle of Death in Alzheimer Disease Brain: The Aberrant Cross Talk Among Energy Metabolism, mTOR Signaling and Protein Homeostasis Revealed by Redox Proteomics," Antioxidants and Redox Signaling 26, 364-387 (2017).

626. A. Tramutola, A. Arena, C. Cini, D.A. Butterfield, and Eugenio Barone, “Modulation of GLP-1 Signaling as a Novel Therapeutic Approach in the Treatment of Alzheimer Disease Pathology,” Expert Reviews of Neurotherapeutics 17, 59-75 (2017).

625. A. Tramutola, F. Di Domenico, E. Barone, A. Giorgi, L. di Francesco, M.E. Schinina, R. Coccia, E. Head, D.A. Butterfield*, and M. Perluigi, “Polyubiquityinylation Profile in Down Syndrome Brain Prior to and after Development of Alzheimer Neuropathology,” Antioxidants and Redox Signaling 26, 280-298 (2017). *Co-Corresponding Author.

624. D.A. Butterfield and M. Perluigi, “Redox Proteomics: A Key Tool for New Insights into Protein Modification with Relevance to Disease,” Antioxidants and Redox Signaling 26, 277-279 (2017).

623. X. Ren, D.K. St. Clair, and D.A. Butterfield, “Dysregulation of cytokine mediated chemotherapy induced cognitive impairment,” Pharmacological Research 117, 267-273 (2017).

622. A.M. Swomley, J.C. Triplett, J.T. Keeney, G. Warrier, K.J. Pearson, J.A. Mattison, R. de Cabo, J. Cai, J.B. Klein, and D.A. Butterfield, “Comparative Proteomic Analyses of the Parietal Lobe from Rhesus Monkeys Fed a High Fat/Sugar Diet with and without Resveratrol Supplementation, Relative to a Healthy Diet: Insights into Role of Unhealthy Diets and Resveratrol on Function,” Journal of Nutritional Biochemistry 39, 169-179 (2017).

621. D.A. Butterfield and T.T. Reed, “Lipid Peroxidation and Tyrosine Nitration in Traumatic Brain Injury: Insights into Secondary Injury from Redox Proteomics,” Proteomics-Clinical Applications 10, 1191-1204 (2016).

620. S.A. Farr, M.L. Niehoff, M.A. Ceddia, K.A. Herrlinger, B.J. Lewis, S. Feng, A. Welleford, D.A. Butterfield, and J.E. Morley, “ Effect of Botanical Extracts Containing Carnosic Acid or Rosmarinic Acid on Learning and Memory in SAMP8 Mice,” Physiology & Behavior 165, 328-338 (2016).

619. P. Gupta, C.T. Jordan, M.I. Mitov, D.A. Butterfield, J.Z. Hilt, T.D. Dziubla, “Controlled Circumin Release via Conjugation intp PBAE Nanogels Enhances Mitochondrial Protection Against Oxidative Stress,” International Journal of Pharmaceutics 511, 1012-1021 (2016).

618. A.-L, Lin, D.A. Butterfield, and A. Richardson, “mTOR: Alzheimer’s Disease Prevention for APOE4 Carriers,” Oncotarget 7, 44873 (2016).

617. M. Perluigi, F. Di Domenico, E. Barone, and D. A. Butterfield, “Abberant Protein Phosphorylation in Alzheimer Disease Brain Disturbs Pro-Survival and Cell Death Pathways,” Biochimica et Biophysica Acta-Moleclar Basis of Disease 1862, 1871-1882 (2016).

616. M. Mitov, V.S. Patil, M.C. Alstott, T. Dziubla, and D.A. Butterfield, “In Vitro Cellular Assays for Oxidative Stress and Biomaterial Response,” in Oxidative Stress and Biomaterials, (T. Dziubla and D.A. Butterfield, Eds.), Elsevier Press, Amsterdam, pp. 145-186 (2016).

615. T. Dziubla, and D.A. Butterfield, Oxidative Stress and Biomaterials, Elsevier Press, Amsterdam (2016).

614. W. Zhang, D. St. Clair, D.A. Butterfield, and M. Vore,“Loss of Mrp1 Potentiates Doxorubicin-induced Cytotoxicity in Neonatal Mouse Cardiomyocytes and Cardiac Fibroblasts,” Toxicological Sciences 151, 44-56 (2016).

613. A. Tramutola, G. Pupo, F. Di Domenico, E. Barone, A. Arena, C. Lanzillotta, D. Brokeaart, C. Blarzion, E. Head, D.A. Butterfield, and M. Perluigi, “Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain Is Associated with a Pro-apoptotic Phenotype,” Journal of Alzheimers Disease 52, 359-371 (2016).

612. J.C. Triplett, A. Swomley, J. Kirk, K. Grimes, K.atilyn Lewis, M. Orr, K. Rodriguez, J. Cai, J.B. Klein, R. Buffenstein, and D.A. Butterfield,“Reaching Out to Send a Message: Mechanisms Promoting Extended Healthspan in the Long-lived Naked Mole-Rat May Involve Neurite Outgrowth and Neurotransmission,” Neurochemical Research 41, 1625-1634 (2016).

611.D.A. Butterfield, Erika M. Palmieri, and A.Castegna, “Clinical Implications From Proteomic Studies In Neurodegenerative Diseases: Lessons From Mitochondrial Proteins,” Expert Rev Proteomics, 13, 259-274 (2016).

610. F. Di Domenico, G. Pupo, E. Giraldo, A. Lloret, M.C. Badia, M.E. Schinina, A. Giorgi,D. A. Butterfield, J. Vina, M. Perluigi, “Autoantibodies Profile in Matching CSF and Serum from AD and aMCI patients: Potential Pathogenic Role and Link to Oxidative Damage,” Curr Alzheimer’s Res 13, 112-122 (2016).

609. A. Tramutola, F. Di Domenico, E. Barone, M. Perluigi, and D.A. Butterfield, “It’s All About U(biquitin): Role of the Altered Ubiquitin Proteasome System and UCHL1 in Alzheimer Disease,” Oxidative Medicine and Cellular Longevity 2016, (2016).

608. S. Miriyala, C. Thippakorn, L. Chaiswing, Y. Xu, T. Noel, A. Tovmasyan, I. Batinic-Haberle, C. Vander Kooi, W. Chi, A. Abdel Latif, M. Panchatcharam, V. Prachayasittikul, D.A. Butterfield, M. Vore, J. Moscow, and Daret K. St. Clair, “ Novel Role of 4-Hydroxy-2-Nonenal in AIFm2-Mediated Mitochondrial Stress Signaling,” Free Radical Biology & Medicine 91, 68-80 (2016).

607. E. Barone, F. Di Domenico, T. Cassano, A. Arena, A. Tramutola, R. Coccia, D.A. Butterfield*, and M. Perluigi, “Impairment of Biliverdin Reductase-A Promotes Brain Insulin Resistance in Alzheimer Disease: A New Paradigm,” Free Radical Biology & Medicine 91, 127-142 (2016).*Co-Corresponding Author.

606. F. Di Domenico, G. Pupo, E. Giraldo, M.-C. Badia, P. Monllor, A. Lloret, M.E. Schinina, A. Giorgi, A. Tramutola, D.A. Butterfield, J. Vina, and M. Perluigi, “Oxidative Signature of Cerebrospinal Fluid from Mild Cognitive Impairment and Alzheimer Disease Patients,” Free Radical Biology & Medicine 91, 1-9 (2016).

605. F. Di Domenico, M. Perluigi, and ,D.A. Butterfield, "Redox Proteomics in Human Biofluids: Sample Preparation, Separation, and Immunochemical Tagging for Analysis of Protein Oxidation” Methods in Molecular Biology 1303, 391-403 (2016).

604. D.A. Butterfield, “Redox Signaling in Neurodegeneration,” Neurobiology of Disease 84, 1-3 (2015).

603. Jeriel T. Keeney and D.A. Butterfield, “Vitamin D Deficiency and Alzheimer Disease: Common Links,” Neurobiology of Disease 84, 84-98 (2015).

602. M. Perluigi, F. Di Domenico, and D.A. Butterfield, “mTOR Signaling in Aging and Neurodegeneration: At the Crossroads between Metabolism Function and Impairment of Autophagy,” Neurobiology of Disease 84, 39-49 (2015).

601. E. Barone and D.A. Butterfield, “Insulin Resistance in Alzheimer Disease: Is Heme Oxygenase-1 an Achille’s Heel?” Neurobiology of Disease 84, 69-77 (2015).

600. J.C. Triplett, A.M. Swomley, J. Cai, J.B. Klein, and D.A. Butterfield, “Quantitative Phosphoproteomic Analyses of the Inferior Parietal Lobule from Three Different Pathological Stages of Alzheimer’s Disease," Journal of Alzheimer’s Disease 49, 45-62 (2016).

599. A.M. Swomley and D.A. Butterfield, “Oxidative Stress in Alzheimer Disease and Mild Cognitive Impairment: Evidence from Human Data Provided by Redox Proteomics,” Archives of Toxicology 89, 1669-1680 (2015).

598. E. Barone, G. Cenini, F. Di Domenico, T. Noel, C. Wang, M. Perluigi , D.K. St. Clair, and D.A. Butterfield, “Basal Brain Oxidative and Nitrosative Stress Levels Are Finely Regulated by the Interplay between MnSOD and p53,” J. Neurosci. Res. 93, 1728-1739 (2015).

597. F. Di Domenico, M. Perluigi, and D.A. Butterfield, "Redox Proteomics in Human Biofluids: Sample Preparation, Separation, and Immunochemical Tagging for Analysis of Protein Oxidation,” Methods in Molecular Biology 1303, 391-403 (2015).

596. Y. Zaytseva, J.W. Harris, M.I. Mitov, J.T. Kim, D.A. Butterfield, E.Y. Lee, H.L. Weiss, T. Gao, and B.M. Evers, “Increased Expression of Fatty Acid Synthase Provides a Survival Advantage to Colorectal Cancer Cells via Upregulation of Cellular Respiration,” Oncotarget 6, 18891-18904 (2015).

595. J.C. Triplett, A. Tramutola, A. Swomley, J. Jirk, K. Grimes, L. Lewis, M. Orr, K. Rodriguez, J. Cai, J.B. Klein, M. Perluigi, R. Buffenstein and D. A. Butterfield, “Age-related Changes in the Proteostasis Network in the Brain of the Naked Mole-rat: Implications Promoting Healthy Longevity,” Biochimica et Biophysica Acta-Molecular Basis of Disease 1852, 2213-2224 (2015).

594. J.T.R. Keeney, S. Miriyala, T. Noel, J.A. Moscow, D.K. St. Clair, and D.A. Butterfield, "Superoxide Induces Protein Oxidation in Plasma and TNF-α Elevation in Macrophage Culture: Insights into Mechanisms of Neurotoxicity Following Doxorubicin Chemotherapy,” Cancer Letters 367, 157-161 (2015).

593. J. C. Triplett, A. Swomley, J. Kirk, K. Lewis, M. Orr, K. Rodriguez, J. Cai, J.B. Klein, R. Buffenstein, and D.A. Butterfield, “Metabolic Clues to Salubrious Longevity in the Brain of the Longest-lived Rodent: the Naked Mole-Rat,” Journal of Neurochemistry 134, 538-550 (2015).

592. C.–H. Chen, W. Li, R. Sultana, M.-H. You, A. Kondo, K. Shahpasand, B.M. Kim, M. Luo, M. Nechama, Y.-M. Lin, Y. Yao, T.H. Lee, X.Z. Zhou, A.M. Swomley, D.A. Butterfield, Y. Zhang, and K.P. Lu, “Pin 1 Cysteine-113 Oxidative Inhibits Its Catalytic Activity and Cellular Function in Alzheimer’s Disease,” Neurobiology of Disease," Neurobiology of Disease 76, 13-23 (2015).

591. J. Hayslip, E.V. Dressler, H. Weiss, T.J. Taylor, M. Chambers T. Noel, S. Miriyala, J.T.R. Keeney, X. Ren, R. Sultana, M. Vore, D.A. Butterfield, D. St. Clair, and J.A. Moscow, “Plasma TNF-a and Soluble TNF Receptor Levels after Doxorubicin with or without Co-administration of Mesna—A Randomized Cross-over Clinical Study,” PLoS One 10, e124988 (2015).

590. J. Triplett, Z. Zhang, R. Sultana, J. Cai, J. Klein, H. Büeler, and D.A. Butterfield, "Quantitative Expression Proteomics and Phosphoproteomics Profiles of Brain from PINK1 Knockout Mice: Insights into Mechanisms of Familial Parkinson Disease," J Neurochem 133, 750-765 (2015).

589. A. Tramutola, J. Triplett, F. Di Domenico, D.M. Niedowicz, M.P. Murphy, R. Coccia, M. Perluigi, and D.A. Butterfield, “Alteration of mTOR Signaling Occurs Early in the Progression of Alzheimer Disease: Analysis of Brain from Subjects with Preclinical AD, Amnestic Mild Cognitive Impairment and Late-Stage AD,” J Neurochem 133, 739-749 (2015).

588. F. Di Domenico, G. Pupo, C. Mancuso, E. Barone, F. Paolini, A. Arena, C. Blarzino, F.A. Schmitt, E. Head, D.A. Butterfield, and M. Perluigi, “Bach1 Overexpression in Down Syndrome Correlates with the Alteration of the HO-1/BVR-A System: Insights for Transition to Alzheimer Disease,” Journal of Alzheimer’s Disease 44, 1107-1120 (2015).

587. F. Di Domenico, E. Barone, M. Perluigi, and D.A. Butterfield, “Strategy to Reduce Free Radical Species in Alzheimer’s Disease: An Update of Selected Antioxidants,” Expert Review of Neurotherapeutics 22, 1-22 (2014).

586. T.T. Reed, Z.P. Sellers, and D.A. Butterfield, "Lipid Peroxidation in Age-related Neurodegenerative Disorders," in Lipid Oxidation in Health and Disease," C.M. Spickett and H.J. Forman, Eds., Taylor and Francis Publishers, Boca Raton, FL., pp. 329-361 (2015).

585. M. Perluigi and D.A. Butterfield, “Down Syndrome as a Special Case of Oxidatively Induced Developmental Dysregulation,” in Perinatal and Prenatal Disorders, P.A. Dennery, G. Buonocore, and O.D. Saugstad, Eds., Springer, New York, pps. 127-142 (2014).

584. G. Cenini, A. Fiorini, R. Sultana, M. Perluigi, J. Cai, J.B. Klein, E. Head, and D.A. Butterfield, “An Investigation of the Molecular Mechanisms Engaged Before and After the Development of Alzheimer Disease Neuropathology in Down Syndrome: A Proteomics Approach,” Free Radical Biology & Medicine 76, 89-95 (2014).

583. D.A. Butterfield, F. Di Domenico, A.M. Swomley, E. Head, and M. Perluigi, “Redox Proteomics Analysis to Decipher the Neurobiology of Alzheimer-like Neurodegeneration: Overlaps in Down Syndrome and Alzheimer Disease Brain,” Biochemical Journal 463, 177-189 (2014).

582. S.S. Hardas, R. Sultana,W. Govind, M. Dan, P. Wu, E. Grulke, M. Tseng, J. Unrine, U. Graham, R. Yokel, and D.A. Butterfield, “Rat Hippocampal Responses Up to 90 Days after a Single Nanoceria Dose Extends a Hierarchical Oxidative Stress Model for Nanoparticle Toxicity,” Nanotoxicology 81, 155-166 (2014).

581. M.T. Tseng, Q. Fu, K. Lor, R. Fernandez-Botron, Z.B. Deng, U.M. Graham, D.A. Butterfield, E. Grulke, and R.A. Yokel, "Persistent Hepatic Structural Alterations Following Nanoceria Vascular Infusion in the Rat," Toxicologic Pathology 42, 984-996 (2014).

580. U.M. Graham, M.T. Tseng, J.B. Jasinski, R.A. Yokel, J.M. Unrine, B.H. Davis, A.K. Dozier, S.S. Hardas, R. Sultana, E.A. Grulke, and D.A. Butterfield, “In Vivo Processing of Ceria Nanoparticles Inside Liver: Impact on Free Radical Scavenging Activity and Oxidative Stress,” ChemPlusChem 79, 1083-1089 (2014).

579. D.A. Butterfield, “THE 2013 SFRBM DISCOVERY AWARD: Selected Discoveries from the Butterfield Laboratory of Oxidative Stress and Its Sequela in Brain in Cognitive Disorders Exemplified by Alzheimer Disease and Chemotherapy Induced Cognitive Impairment,” Free Radical Biology & Medicine 74, 157-174 (2014).

578. D. A. Butterfield, Fabio Di Domenico, and Eugenio Barone, "Elevated Risk of Type 2 Diabetes for Development of Alzheimer Disease: a Key Role for Oxidative Stress in Brain," Biochimica et Biophysica Acta - Molecular Basis of Disease 1842, 1693-1706 (2014).

577. F. Di Domenico, E. Head, D.A. Butterfield, and M. Perluigi, "Oxidative Stress and Proteostasis Network: Culprit and Casualty of Alzheimer’s-Like Neurodegeneration," Advances in Geriatrics 2014, 1-14 (2014).

576. S. Förster, A.S. Welleford, J.C. Triplett, R. Sultana, B. Schmitz, and D.A. Butterfield, “Increased O-GlcNAc Levels Correlate with Decreased O-GlcNAcase Levels in Alzheimer Disease Brain,” Biochimica et Biophysica Acta - Molecular Basis of Disease 1842, 1333-1339 (2014).

575. A.M. Swomley, S. Forster, J. Keeney, J. Triplett, Z. Zhang, R. Sultana, and D.A. Butterfield, “Abeta, Oxidative Stress in Alzheimer Disease: Evidence Based on Proteomics Studies,” Biochimica et Biophysica Acta 1842, 1248-1257 (2014).

574. D.A. Butterfield, F. Di Domenico, and R.A.S. Robinson, “Mass Spectrometry and Redox Proteomics: Applications in Disease,” Mass Spectrometry Reviews 33, 277-301 (2014).

573. M. Perluigi, G. Pupo, A. Tramutola, C. Cini, R. Coccia, E. Barone, E. Head, D.A. Butterfield, and F. Di Domenico, “Neuropathological Role of PI3K/AKT/mTOR Axis in Down Syndrome Brain,” Biochim. Biophys. Acta-Molec. Basis Dis. 1842, 1144-1153 (2014).

572. F. Di Domenico, G. Pupo, A. Tramutola, A. Giorgi, M. Eugenia Schininà, R. Coccia, E. Head, D.A. Butterfield, and M. Perluigi, “Redox Proteomics Analysis of HNE-Modified Proteins in DS Brain: Clues for Understanding Development of Alzheimer Disease,” Free Radical Biology & Medicine 71, 270-280 (2014).

571. Y. Zhao, S. Miriyala, L. Miao, M. Mitov, D. Schnell, S. Dhar, J. Cai, J.B. Klein, R. Sultana, D.A. Butterfield, M. Vore, S. Bondada, and D.K. St. Clair, ”Redox Proteomic Identification of HNE-bound Mitochondrial Proteins in Cardiac Tissues Reveals a Systemic Effect on Energy Metabolism after Doxorubicin Treatment,” Free Radical Biology & Medicine 72, 55-65 (2014).

570. E. Barone, F. Di Domenico, and D.A. Butterfield, “Statins More Than Cholesterol Lowering Agents in Alzheimer Disease: Their Pleiotropic Functions as Potential Therapeutic Targets” Biochemical Pharmacology 88, 605-616 (2014).

569. M. Perluigi, F. Di Domenico, and D.A. Butterfield “Unraveling the Complexity of Neurodegeneration in Brains of Subjects with Down Syndrome: Insights from Proteomics,” Proteomics Clinical Applications 8, 73-85 (2014).

568. L. Ulatowski, R. Parker, G. Warrier, R. Sultana, D.A. Butterfield, and D. Manor, "Vitamin E is Essential for Purkinje Neuron Integrity," Neuroscience 260, 120-129 (2014).

567. M. Perluigi, A.M. Swomley, and D.A. Butterfield, “Redox Proteomics and the Dynamic Molecular Landscape of the Aging Brain,” Ageing Research Reviews 13, 75-89 (2014).

566. S.A. Farr, J.L. Ripley, R. Sultana, Z. Zhang, M.L. Niehoff, T.L. Platt, M.P. Murphy, J.E. Morley, V. Kumar, and D.A. Butterfield, “Antisense Oligonucleotide Against GSK-3b in Brain of SAMP8 Mice Improves Learning and Memory and Decreases Oxidative Stress: Involvement of Transcription Factor Nrf2 and Implications for Alzheimer Disease,” Free Radical Biology and Medicine 67, 387-395 (2014).

565. D.A. Butterfield and I. Dalle-Donne, "Redox Proteomics: From Protein Modification to Cellular Dysfunction and Disease," Mass Spectrometry Reviews 33, 1-6 (2014).

564. E. Barone, F. Di Domenico, C. Mancuso, and D.A. Butterfield, “The Janus Face of the Heme Oxygenase/Biliverdin Reductase System in Alzheimer Disease: It's Time for Reconciliation,” Neurobiology of Disease 62,144-159 (2014).

563. R. Sultana and D.A. Butterfield, "Oxidative Modification of Brain Proteins in Alzheimer Disease: Prespective on Future Studies Based on Results of Redox Proteomics Studies," Journal of Alzheimer's Disease 33, S243-S251 (2013).

562. V. Makani, R. Sultana, K. Sie, D. Orjiako, M. Tat, A. Dowling, J. Cai, WM Pierce, D.A. Butterfield, J.W. Hill, and J. Park, "Annexin A1 Complex Mediates Oxytocin Vesicle Transport" Journal of Neuroendocrinology 25, 1241-1254 (2013).

561. R. Sultana, A.M. Swomley, and D.A. Butterfield, “Brain Oxidative Stress in the Pathogenesis and Progression of Alzheimer Disease,” in Studies on Alzheimer’s Disease, D. Pratico and P. Mecocci, Eds., Humana Press/Springer, New York, pp. 99-118 (2013).

560. R. Sultana, G. Cenini, and D.A. Butterfield, “Biomarkers of Oxidative Stress in Neurodegenerative Diseases,” in Molecular Basis of Oxidative Stress: ��vlog�ٷ��, Mechanisms, and Disease Pathogenesis, F.A. Villamena, Editor, John Wiley & Sons, Inc., Hoboken, New Jersey, pps. 359-376 (2013).

559. R. Sultana, M. Baglioni, R. Cecchetti, J. Cai, J.B. Klein, P. Bastiani, C. Ruggiero, P. Mecocci, and D.A. Butterfield, “Lymphocyte Mitochondria: Toward Identification of Peripheral Biomarkers in Progression of Alzheimer Disease,” Free Radical Biology & Medicine 65, 595-606 (2013).

558. D.A. Butterfield, A. Swomley, and R. Sultana, "Amyloid β-Peptide 1-42-induced Oxidative Stress in Alzheimer Disease: Importance in Disease Pathogenesis and Progression," Antioxidant Redox Signal 19, 823-835 (2013).

557. J.T. Keeney, S. Forster, R. Sultana, L.D. Brewer, C.S. Latimer, J. Cai, J.B. Klein, N.M Porter, and D.A. Butterfield, "Dietary Vitamin D Deficiency in Rats from Middle- to Old-age Leads to Elevated Tyrosine Nitration and Proteomics Changes in Levels of Key Proteins in Brain: Implications for Low Vitamin D-dependent Age-Related Cognitive Decline," Free Radical Biology and Medicine 65, 324-334 (2013).

556. R. Sultana, M. Perluigi, and D.A. Butterfield, “Lipid Peroxidation Triggers Neurodegeneration: A Redox Proteomics View into the Alzheimer Disease Brain,” Free Radic. Biol. Med. 62, 157-169 (2013).

555. A. Fiorini, R. Sultana, S. Forster, M. Perluigi, G. Cenini, C. Cini, J. Cai, J.B. Klein, S.A. Farr, M.L. Niehoff, J.E. Morley, V.B. Kumar, and D.A. Butterfield, “Antisense Directed Against PS-1 Gene Decreases Brain Oxidative Markers in Aged Senescence Accelerated Mice (SAMP8) and Reverses Learning and Memory Impairment: A Proteomics Study,” Free Radical Biology and Medicine 65, 1-14 (2013).

554. F. Di Domenico, R. Coccia, A. Cocciolo, M.P. Murphy, G. Cenini, E. Head, D.A. Butterfield, A. Giorgi, M.E. Schininà, C. Mancuso, C. Cini, and M. Perluigi, “Impairment of Protestasis Network in Down Syndrome Prior to the Development of Alzheimer’s Disease Neuropathology: Redox Proteomics Analysis of Human Brain,” Biochim. Biophys. Acta—Molec. Basis Dis. 1832, 1249-1259 (2013).

553. R.A.S. Robinson and D.A. Butterfield, "Insights from Proteomics into Mild Cognitive Impairment, Likely the Earliest Stage of Alzheimer's Disease, in Alzheimer's Disease Research Compendium, M.-K. Sun, Ed., Nova Science Publishers, Columbus, OH, pp. 97-116 (2013).

552. S.S. Hardas, R. Sultana, A.M. Clark, C. Bracket, L.I. Szweda, M.P. Murphy, and D. A. Butterfield, “Oxidative Modification of Lipoic Acid by HNE in Alzheimer Disease Brain,” Redox Biology 1, 80-85 (2013).

551. J.T. Keeney, A.M. Swomley, S. Förster, J.L. Harris, R. Sultana, and D.A. Butterfield, “Apolipoprotein A-I: Insights From Redox Proteomics for Its Role in Neurodegeneration,” Proteomics—Clinical Applications 7, 109-122 (2013).

550. P. Jungsuwadee, T. Zhao, E.I. Stolarczyk, C.M. Paumi, D.A. Butterfield, D.K. St..Clair, and M. Vore, “The G671V Variant of MRP1/ABCC1 Links Doxorubicin-Induced Acute Cardiac Toxicity to Disposition of the Glutathione Conjugate of 4-Hydroxy-2-Trans-��ǲԱ�Բ��,” Pharmacogenetics and Genomics Journal 22, 273-284 (2012).

549. F. Di Domenico, M. Perluigi, and D.A. Butterfield, “Redox Proteomics Studies on C.elegans Models: A Simple Organism that Provides Insights into Complex Neurodegenerative Disorders,” European Journal of Neurodegenerative Disorders 1, 279-291 (2012).

548. A. Fiorini, R. Sultana, E. Barone, G. Cenini, M. Perluigi, C. Mancuso, J. Cai, J.B. Klein, D. St. Clair, and D.A. Butterfield, “Lack of p53 Affects the Expression of Several Brain Mitochondrial Proteins: Insights From Proteomics into Important Pathways Regulated by p53,” PLoS One 2012;7, e49846 (2012).

547. C. Pocernich, D.A. Butterfield, and L. Head, “Diet and Brain Aging: Effects on Cell and Mitochondrial Function and Structure,” in , (R.R. Watson and V.R. Preedy, Eds.), Elsevier Publishers, Amsterdam, 249-262 (2012).

546. R. Sultana, G. Cenini, and D.A. Butterfield, “SAMP8: A Model to Understand the Role of Oxidative Stress in Age-Related Diseases Including Alzheimer’s Disease,” in The Senescence Accelerated Mouse (SAM): Achievements and Future Directions, (T. Takeda, Ed.), Elsevier Publishers, Amsterdam, 361-370 (2012).

545. R. Khanna, S.M. Wilson, J.M. Brittain, J. Weimer, R. Sultana, A. Butterfield, and K. Hensley, “Opening Pandora’s Jar: A Primer on the Putative Roles of CRMP2 in a Panoply of Neurodegenerative, Sensory and Motor Neuron, and Central Disorders,” Future Neurology 7, 749-771 (2012).

544. F. Di Domenico, E. Barone, C. Mancuso, M. Perluigi, A. Cocciolo, P. Mecocci, D.A. Butterfield, and R. Coccia, “HO-1/BVR-A System Analysis in Plasma from Probable Alzheimer's Disease and Mild Cognitive Impairment Subjects: A Potential Biochemical Marker for the Prediction of the Disease,” Journal of Alzheimer's Disease 32, 277-289 (2012).

543. S.S. Hardas, R. Sultana, G. Warrier, M. Dan, R.L. Florence, P. Wu, E.A. Grulke, M.T. Tseng, J.M. Unrine, U.M. Graham, R.A. Yokel, and D.A. Butterfield, “Rat Brain Pro-Oxidant Effects of Peripherally Administered 5 nm Ceria 30 Days After Exposure,” Neurotoxicology 33, 1147-1155 (2012).

542. A. Cocciolo, F. Di Domenico1, R. Coccia, A. Fiorini, J. Cai, W.M. Pierce, P. Mecocci, D.A. Butterfield, and M. Perluigi, “Decreased expression and increased oxidation of plasma haptoglobin in Alzheimer disease: Insights From redox proteomics,” Free Radic. Biol. Med. 53, 1868-1876 (2012).

541. D.A. Butterfield, M. Perluigi, T. Reed, T. Muharib, C. Hughes, R. Robinson, and R. Sultana, “Redox Proteomics in Selected Neurodegenerative Disorders. From its Infancy to Future Applications,” Antioxidants and Redox Signaling 17, 1610-1655 (2012).

540. M. Perluigi, R. Coccia, and D.A. Butterfield, “4-Hydroxy-2-Nonenal, a Reactive Product of Lipid Peroxidation, and Neurodegenerative Diseases: A Toxic Combination Illuminated by Redox Proteomics Studies,” Antioxidants and Redox Signaling 17, 1590-1609 (2012).

539. R. Sultana, R.A.S. Robinson, M. Bader Lange, A. Fiorini, V. Galvan, J. Fombonne, A. Baker, O. Gorostiza, J. Zhang, J. Cai, W. Pierce, D. Bredesen, and D.A. Butterfield, “Do Proteomics Analyses Provide Insights into Reduced Oxidative Stress in Brain of an Alzheimer Disease Transgenic Mouse Model with an M631L Amyloid Precursor Protein Substitution and Thereby the Importance of Amyloid-Beta-Resident Methionine 35 in Alzheimer Disease Pathogenesis?” Antioxidants and Redox Signaling 17, 1507-1514 (2012).

538. F. Di Domeico, R. Sultana, A. Ferree, K. Smith, E. Barone, M. Perluigi, R. Coccia, W. Pierce, J. Cai, C. Mancuso, R. Squillace, M. Weingele, I. Dalle-Donne, B. Wolozin, and D.A. Butterfield, "Redox Proteomics Analyses of the Influence of Co-Expression of Wild Type or Mutated LRRK2 and Tau on C. elegans Protein Expression and Oxidative Modification: Relevance to Parkinson Disease," Antioxidants and Redox Signaling 17, 1490-1506 (2012).

537. D.A. Butterfield and I. Dalle-Donne, "Redox Proteomics," Antioxidants and Redox Signaling 17, 1487-1489 (2012).

536. O.V. Tsyusko, S.S. Hardas, W.A. Shoults-Wilson, C.P. Starnes, G. Joice, D.A. Butterfield, and J.M. Unrine, “Short-Term Molecular-Level Effects of Silver Nanoparticle Exposure on the Earthworm, Eisenia Fetida,” Environmental Pollution 171, 249-255 (2012).

535. J.T. Keeney, A.M. Swomley, J.L. Harris, A. Fiorini, M.I. Mitov, M. Perluigi, R. Sultana, and D.A. Butterfield, “Cell Cycle Proteins in Brain in Mild Cognitive Impairment: Insights into Progression to Alzheimer’s Disease,” Neurotox. Res. 22, 220-230 (2012).

534. D.A. Butterfield, E. Barone, F. Di Domenico, G. Cenini, R. Sultana, M.P. Murphy, C. Mancuso, and E. Head, "Atorvastatin Treatment in a Dog Preclinical Model of Alzheimer Disease Leads to Up-regulation of Heme Oxygenase-1 and Is Associated with Reduced Oxidative Stress in Brain," Internat. J. Neuropsychopharmacol. 15, 981-987 (2012).

533. M.A. Erickson, P.E. Hartvigson, Y. Morofuji, J.B. Owen, D.A. Butterfield, and W.A. Banks. “Lipopolysaccharide Impairs Amyloid Beta Efflux From Brain: Altered Vascular Sequestration, Cerebrospinal Fluid Reabsorption, Peripheral Clearance and Transporter Function at the Blood-Brain Barrier,” J. Neuroinflammation 9, 150 (2012).

532. E. Barone, F. Di Domenico, R. Sultana, R. Coccia, C. Mancuso, M. Perluigi, and D.A. Butterfield, “Heme Oxygenase-1 Posttranslational Modifications in the Brain of Subjects with Alzheimer Disease and Mild Cognitive Impairment,” Free Radical Biology and Medicine 52, 2292–2301 (2012).

531. A.R. Evans, S. Miriyala, D.K. St. Clair, D.A. Butterfield, and R.A. Robinson, “Global Effects of Adriamycin Treatment on Mouse Splenic Protein Levels,” J. Proteome Res. 11, 1054-1064 (2012).

530. P. Jungsuwadee, T. Zhao, E.I. Stolarczyk, C.M. Paumi, D.A. Butterfield, D.K. St.Clair, and M. Vore, “The G671V Variant of MRP1/ABCC1 Links Doxorubicin-Induced Acute Cardiac Toxicity to Disposition of the Glutathione Conjugate of 4-Hydroxy-2-Trans-��ǲԱ�Բ��,” Pharmacogenetics and Genomics Journal 22, 273-284 (2012).

529. E. Barone, G. Cenini, R. Sultana, F. Di Domenico, A. Fiorini, T. Noel, C. Mancuso, D.K. St. Clair, and D.A. Butterfield, “Lack of p53 Decreases Basal Oxidative Stress Levels in Brain Through Up-Regulation of Thioredoxin-1, Biliverdin Rederctase-A, Manganese Superoxide Dismutase, and Nuelear Factor-kapa B,” Antioxidants and Redox Signaling 16, 1407-1420 (2012).

528. R. Siciliano, E. Barone, V. Calabrese, V. Rispoli, D.A. Butterfield, and C. Mancuso, "Experimental Research On Nitric Oxide and the Therapy of Alzheimer Disease: A Challenging Bridge,” CNS Neurol Disord Drug Targets 10, 766-776 (2012).

527. F. De Marco, E. Bucaj, C. Foppoli, A. Fiorini, C. Blarzino, K. Filipi, A. Giorgi, M.E. Schininà, F. Di Domenico, R. Coccia, D.A. Butterfield, and M. Perluigi, “Oxidative Stress in HPV-Driven Viral Carcinogenesis: Redox Proteomics analysis of HPV-16 Dysplastic and Neoplastic Tissues,” Plos One 7, e34366 (2012).

526. M.T. Tseng, X. Lu, X. Duan, S.S. Hardas, R. Sultana, P. Wu, J.M. Unrine, U. Graham, D.A. Butterfield, E.A. Grulke, and R.A. Yokel, "Alteration of Hepatic Structure and Oxidative Stress Induced by Intravenous Nanoceria," Toxicology and Applied Pharmacology 260, 173-182 (2012).

525. R.A. Yokel, T.C. Au, R. MacPhail, S.S. Hardas, D.A. Butterfield, R. Sultana, M. Goodman, M.T. Tseng, M. Dan, A. Hughnazar, J.M. Unrine, U.M. Gram, P. Wn, and E.A. Grulhe, “Distribution, Elimination and Biopersistence to 90 Days of a Systemically-Introduced 30nm Ceria Engineered Nanomaterial in Rats,” Toxicological Sciences 127, 256-268 (2012).

524. F. Di Domenico, G. Casalena, J. Jia, R. Sultana, E. Barone, J. Cai, W.M. Pierce, C. Cini, M. Perluigi, C.M. Davis, N.J. Alkayed, and D.A. Butterfield, "Sex Differences in Brain Proteomes of Nuron-Specific Stat3-Null Mice after Cerebral Ischemia/Reperfusion," Journal of Neurochemistry 121, 680-692(2012).

523. G. Colombo, I. Dalle-Donne, M. Orioli, D. Giustarini, R. Rossi, M. Clerici; Luca Regazzoni, G. Aldini, A. Milzani, D.A. Butterfield, and N. Gagliano, “Oxidative Damage in Human Gingival Fibroblasts Exposed to Cigarette Smoke,” Free Radical Biology & Medicine 52, 1584-1596 (2012).

522. D.A. Butterfield and J.N. Keller, “Antioxidants and Antioxidant Treatment in Disease,” Biochim. Biophys. Acta – Molecular Basis of Disease 1822, 615 (2012).

521. C.B. Pocernich and D.A. Butterfield, "Elevation of Glutathione as a Therapeutic Strategy in Alzheimer Disease,” Biochim. Biophys. Acta – Molecular Basis of Disease 1822, 625-630 (2012).

520. L. Buizza, G. Cenini, C. Lanni, G. Ferrari-Toninelli, C. Prandelli, S. Govoni, E. Buoso, M. Racchi, M. Barcikowska, M. Styczynska, A. Szybinska, D.A. Butterfield, M. Memo, and D. Uberti, “Conformational Altered p53 as an Early Marker of Oxidative Stress in Alzheimer's Disease,” (2012).

519. E. Barone, C. Mancuso, F. Di Domenico, R. Sultana, M.P. Murphy, E. Head, and D.A. Butterfield, “Biliverdin Reductase-A: a Novel Drug Target for Atorvastatin in a Dog Preclinical Model of Alzheimer Disease,” (2012).

518. M. Perluigi and D.A. Butterfield, "Oxidative Stress and Down Syndrome: a Route Toward Alzheimer-like Dementia," (2012).

517. G. Cenini, A. Dowling, T. Beckett, E. Barone, C. Mancuso, M.P. Murphy, H. Levine, I. Lott, F. Schmitt, D.A. Butterfield, and E. Head, “Association Between Frontal Cortex Oxidative Damage and Beta-Amyloid as a Function of Age in Down Syndrome,” Biochim Biophys. Acta-Molec. Basis of Disease 1822, 130-138 (2012).

516. F. Di Domenico, R. Coccia, D.A. Butterfield, and M. Perluigi, “Circulating Biomarkers of Protein Oxidation for Alzheimer Disease: Expectations within Limits,” Biochim. Biophys. Acta- Proteins and Proteomics 1814, 1785-1795 (2011).

515. R.A.S. Robinson, G. Joshi, Q. Huang, R. Sultana, A.S. Baker, J. Cai, W.M. Pierce, D.K. St. Clair, W.R. Markesbery, and D.A. Butterfield, “Proteomics Analysis of Brain Proteins in APP/PS-1 Human Double Mutant Knock-in Mice with Increasing Amyloid β-Peptide Deposition: Insights into the Effects of in vivo Treatment with N-Acetylcysteine as a Potential Therapeutic Intervention in Mild Cognitive Impairment and Alzheimer Disease,”Proteomics 11, 4243-4256 (2011).

514. R.A.S. Robinson, M. Bader Lange, R.Sultana, V. Galvan, J. Fombonne, O. Gorostiza, J. Zhang, G. Warrier, J. Cai, W.M. Pierce,D.E. Bredesen, and D.A. Butterfield, “Differential Expression and Redox Proteomics Analyses of an Alzheimer Disease Transgenic Mouse Model: Effects of the Amyloid-β Peptide of Amyloid Precursor protein(=),” (2011).

513. R. Sultana, R.A.S. Robinson, H. Mohmmad Abdul, F. Di Domenico, D.K. St. Clair, W.R. Markesbery, J. Cai, W.M. Pierce, and D.A. Butterfield, "Proteomics Identification of Specifcally Carbonylated Brain Proteins in APP^NLh/APP^NLh X PS-1^P264L/PS-1^P264L Human Double Mutant Knock-in Mice Model of Alzheimer Disease as a Function of Age,” J. Proteomics 74, 2430-2440 (2011).

512. P.P. Wattamwar, S.S. Hardas, D.A. Butterfield, K.W. Anderson, and T.D. Dziubla, “Tuning of the Pro-Oxidant and Antioxidant Activity of Trolox Through the Controlled Release From Biodegradable Poly(Trolox Ester) Polymers,” (2011).

511. S.B. Martin, G. Cenini, E. Barone, A.L. Dowling, C. Mancuso, D.A. Butterfield, M.P. Murphy, and E. Head, "Coenzyme Q10 and Cognition in Atorvastin-treated Dogs," (2011).

510. C. Mancuso, R. Siciliano, E. Barone, D.A. Butterfield, and P. Preziosi, “Pharmacologists and Alzheimer Disease Therapy: To Boldly Go Where No Scientist Has Gone Before,” (2011).

509. E. Barone, F. Di Domenico, G. Cenini, R. Sultana, R. Coccia, P. Preziosi, M. Perluigi, C. Mancuso, and D.A. Butterfield, “Oxidative and Nitrosative Modifications of Biliverdin Reductase in the Brain of Subjects with Alzheimer Disease and Mild Cognitive Impairment,” (2011).

508. M. Perluigi and D.A. Butterfield, “The Identification of Protein Biomarkers for Oxidative Stress in Down Syndrome,” (2011).

507. D.A. Butterfield, E. Barone, and C. Mancuso, “Cholesterol-Independent Neuroprotective and Neurotoxic Activities of Statins: Perspectives for Statin Use in Alzheimer Disease and Other Age-Related Neurodegenerative Disorders,” (2011).

506. D.A. Butterfield and R.Sultana, “Methionine-35 of Aβ (1–42): Importance for Oxidative Stress in Alzheimer Disease," (2011).

505. F. Di Domenico, R. Sultana, E. Barone, M. Perluigi, C. Cini, C. Mancuso,J. Cai, W.M. Pierce, and D.A. Butterfield, “Quantitative Proteomics Analysis of Phosphorylated Proteins in the Hippocampus of Alzheimer's Disease Subjects,” Journal of Proteomics 74, 1091-1103 (2011).

504. C.B. Pocernich, M.L. Bader Lange, R. Sultana, and D.A. Butterfield, "Nutritional Approaches to Modulate Oxidative Stress in Alzheimer’s Disease," (2011).

503. C.D. Aluise, S. Miriyala, T. Noel, R. Sultana, P. Jungsuwadee, T.J.Taylor, J. Cai, W.M. Pierce, M. Vore, J.A. Moscow, D.K. St. Clair, and D.A. Butterfield, “2-Mercaptoethanesulfonate (MESNA) Prevents Doxorubicin-Induced Plasma Protein Oxidation and TNFa Release,” Free Radical Biology & Medicine 50, 1630-1638 (2011).

502. M. Perluigi, F. Di Domenico, A. Fiorini, A. Cocciolo, A. Giorgi, C. Foppoli, D.A. Butterfield, M. Giorlandino, C. Giorlandino, M.E. Schinina, and R. Coccia, “Oxidative Stress Occurs Early in Down Syndrome Pregnancy: A Redox Proteomics Analysis of Amniotic Fluid,” (2011).

501. R. Sultana, P. Mecocci, F. Mangialasche, R. Cecchetti, and D.A. Butterfield, “Increased Protein and Lipid Oxidative Damage in Mitochondria Isolated From Lymphocytes From Patients with Alzheimer Disease: Insights into the Role of Oxidative Stress in Alzheimer's Disease and Initial Investigations into a Potential Biomarker for this Dementing Disorder,” (2011).

500. R. Sultana and D.A. Butterfield, “Brain Protein Oxidation and Modification for Good or for Bad in Alzheimer’s Disease,” (2011).

499. D.A. Butterfield, "Oxidative Stress in Alzheimer Disease: Synergy Between the Butterfield and Markesbery Laboratories," (2010.

498. D.A. Butterfield "Preface to the Special Issue of NeuroMolecular Medicine in Memory of the Life and Legacy of William R. Markesbery, M.D.," (2011).

497. D.A. Butterfield, T.T. Reed, and R. Sultana,"Roles of 3-Nitrotyrosine- and 4-Hydroxynonenal-Modified Brain Proteins in the Progression and Pathogenesis of Alzheimer's Disease," (2011).

496. R. Sultana and D.A. Butterfield, “Identification of the Oxidative Stress Proteome in the Brain,” (2011).

495. D.A. Butterfield, “Atorvastatin and Aβ(1-40): Not as Simple as Cholesterol Reduction in Brain and Relevance to Alzheimer Disease,” Experimental Neurology 228, 15-18 (2011).

494. E. Barone, F. Di Domenico, G. Cenini, R. Sultana, C. Cini, P. Preziosi, M. Perluigi, C. Mancuso, and D.A. Butterfield, “Biliverdin Reductase-A Protein Levels and Activity in the Brains of Subjects with Alzheimer's Disease and Mild Cognitive Impairment,” (2011).

493. E. Barone, G. Cenini, F. Di Domenico, S. Martin, R. Sultana, C. Mancuso, M. Paul Murphy, E. Head, and D. Allan Butterfield, "Long-term High-dose Atorvastatin Decreases Brain Oxidative and Nitrosative Stress in a Preclinical Model of Alzheimer Disease: a Novel Mechanism of Action," Pharmacological Research 63, 172-180 (2011).

492. D.A. Butterfield and J.B. Owen, “Lectin-Affinity Chromatography Brain Glycoproteomics and Alzheimer Disease: Insights into Protein Alterations Consistent with the Pathology and Progression of this Dementing Disorder,” (2011).

491. C.D. Aluise, R.A.S. Robinson, J. Cai, W.M. Pierce, W.R. Markesbery, and D.A. Butterfield, “Redox Proteomics Analysis of Brains From Subjects with Amnestic Mild Cognitive Impairment Compared to Brains From Subjects with Preclinical Alzheimer's Disease: Insights into Memory Loss in MCI,” (2011).

490. F. Di Domenico, M. Perluigi, D.A. Butterfield, C. Cornelius, and V. Calabrese, “Oxidative Damage in Rat Brain During Aging: Interplay Between Energy and Metabolic Key Target Proteins,” (2010).

489. R.A. Sowell and D.A. Butterfield, “Spontaneous Vertebrate Models of Alzheimer Dementia: Selectively bred strains (SAM strains),” in Animal Models of Dementia, Neuromethods Series, Humana Press Inc.; New York, 271-293 (2010).

488. R. Sultana, F. Di Domenico, M. Tseng, J. Cai, T. Noel, R.L. Chelvarajan, W.D. Pierce, C. Cini, S. Bondada, D.K. St. Clair, and D.A. Butterfield, “Doxorubicin-Induced Thymus Senescence,” (2010).

487. M. Perluigi, F. Di Domenico, A. Giorgi, M.E. Schininà, R. Coccia, C. Cini, F. Bellia, M.T. Cambria, C. Cornelius, D.A. Butterfield, and V. Calabrese, “Redox Proteomics in Aging Rat Brain: Involvement of Mitochondrial Reduced Glutathione Status and Mitochondrial Protein Oxidation in the Aging Process,” (2010).

486. F. Di Domenico, J.B. Owen, R. Sultana, R.A. Sowell, M. Perluigi, C. Cini, J. Cai, W.M. Pierce, and D.A. Butterfield, “The Wheat Germ Agglutinin-Fractionated Proteome of Subjects with Alzheimer's Disease and Mild Cognitive Impairment Hippocampus and Inferior Parietal Lobule: Implications for Disease Pathogenesis and Progression,” (2010).

485. F. Di Domenico, G. Casalena, R. Sultana, J. Cai, W.M Pierce, M. Perluigi, C. Cini, A. Baracca, G. Solaini, G. Lenaz, J. Jia, S.Dziennis, S.J. Murphy, N.J. Alkayed, and D.A. Butterfield, “Involvement of STAT3 in Mouse Brain Development and Sexual Dimorphism: A Proteomics Approach,” (2010).

484. R.E. Haskew-Laytona, J.B. Payappilly, N.A. Smirnova, T.C. Ma, K.K. Chan, T.H. Murphy, H. Guo, B. Langley, R. Sultana, D.A. Butterfield, S. Santagata, M.J. Alldred, I.G. Gazaryan, G.W. Bell, S.D. Ginsberg, and R.R. Ratan, “Controlled Enzymatic Production of Astrocytic Hydrogen Peroxide Protects Neurons From Oxidative Stress Via An Nrf2-Independent Pathway,” (2010).

483. J.B. Owen, R. Sultana, C.D. Aluise, M.A. Erickson, T.O. Price, G. Bu, W.A. Banks, and D.A. Butterfield, “Oxidative Modification to LDL-related Receptor Protein 1 (LRP1) in Hippocampus From Subjects with Alzheimer's Disease: Implications for Aβ Accumulation in AD Brain,” (2010).

482. G. Cenini, G. Maccarinelli, C. Lanni, S.A. Bonini, G. Ferrari-Toninelli, S. Govoni, M. Racchi, D.A. Butterfield, M. Memo, and D. Uberti, “Wild Type But Not Mutant APP is Involved in Protective Adaptive Responses Against Oxidants,” (2010).

481. J.B. Owen and D.A. Butterfield, "Measurement of Oxidized/Reduced Glutathione Ratio," (2010).

480. Q. Huang, C, Aluise, G. Joshi, R. Sultana, D. St. Clair, W. Markesbery, and D.A. Butterfield, "Potential In Vivo Amelioration By N-Acetyl-L-Cysteine of Oxidative Stress in Brain in Human Double Mutant APP/PS-1 Knock-In Mice: Towards Therapeutic Modulation of Mild Cognitive Impairment (MCI)," (2010).

479. S.S. Hardas, D.A. Butterfield, R. Sultana, M. Dan, R.L. Florence, J.M. Unrine, U.M. Graham, P. Wu, E.A. Grulke, M.T. Tseng, and R.A. Yokel, “Brain Distribution and Toxicological Evaluation of a Systemically Delivered Engineered Nanoscale Ceria,” (2010).

478. D.A. Butterfield, M.L. Bader Lange, and R. Sultana, "Involvements of the Lipid Peroxidation Product, HNE, in the Pathogenesis and Progression of Alzheimer's Disease," (2010).

477. C.D. Aluise, R. Sultana, J. Tangpong, M. Vore, D. St. Clair, J.A. Moscow, and D.A. Butterfield, "Chemo Brain (Chemo Fog) as a Potential Side Effect of Doxrubicin Administration: Role of Cytokine-induced, Oxidative/Nitrosative Stress in Cognitive Dysfunction," in

476. C.D. Aluise, R.A.S. Robinson, T.L. Beckett, M.P. Murphy, J. Cai, W.M. Pierce, W.R. Markesbery, and D.A. Butterfield, Preclinical Alzheimer Disease: Brain Oxidative Stress, Aβ Peptide and Proteomics,” (2010).

475. D.A. Butterfield, S.S. Hardas, and M.L. Bader Lange, “Oxidatively Modified Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) and Alzheimer Disease: Many Pathways to Neurodegeneration,” (2010).

474. M. Perluigi, F. Di Domenico, C. Blarzino, C. Foppoli, C. Cini, A. Giorgi, C. Grillo, F. De Marco, D.A. Butterfield, M.E. Schininna, and R. Coccia, “Effects of UVB-Induced Oxidative Stress on Protein Expression and Specific Protein Oxidation in Normal Human Epithelial Keratinocytes: A Proteomics Approach,” (2010).

473. F. Di Domenico, R. Sultana, G.F. Tiu, N.N. Scheff, M. Perluigi, C. Cini, and D.A. Butterfield, “Protein Levels of Heat Shock Proteins 27, 32, 60, 70, 90 and Thioredoxin-1 in Amnestic Mild Cognitive Impairment: An Investigation on the Role of Cellular Stress Response in the Progression of Alzheimer's Disease,” (2010).

472. D.A. Butterfield, "William R. Markesbery, M.D.: A Legacy of Excellence in Alzheimer's Disease Research and a Life Well Lived," (2010).

471. M.L. Lange, D.K. St. Clair, W.R. Markesbery, C.M. Studzinski, M.P. Murphy, and D.A. Butterfield, “Age-Related Loss of Phospholipid Asymmetry in APPNLh/APPNLh x PS-1P264L/PS-1P264L Human Double Mutant Knock-In Mice: Relevance to Alzheimer Disease,” (2010).

470. G. Joshi, C. D. Aluise, M.P. Cole, R. Sultana, M. Vore, D.K. St. Clair, and D.A. Butterfield, “Alterations in Brain Antioxidant Enzymes and Redox Proteomic Identification of Oxidized Brain Proteins Induced by the Anti-Cancer Drug Adriamycin: Implications for Oxidative Stress-Mediated Chemobrain,” (2010).

469. R. Sultana, M. Perluigi, S. Newman, W. Pierce, C. Cini, R. Coccia, and D.A. Butterfield, "Redox Proteomic Analysis of Carbonylated Brain Proteins in Mild Cognitive Impairment and Early Alzheimer's Disease," (2010).

468. Y.J. Suzuki, M. Carini, and D.A. Butterfield, “Protein Carbonylation,” (2010).

467. R. Sultana, W.A. Banks, and D.A. Butterfield, "Decreased Levels of PSD95 and Two Associated Proteins and Increased Levels of BCl2 and Caspase 3 in Hippocampus From Subjects with Amnestic Mild Cognitive Impairment: Insights into Their Potential Roles for Loss of Synapses and Memory, Accumulation of Aβ, and Neurodegeneration in a Prodromal Stage of Alzheimer’s Disease," (2010).

466. V. Calabrese, C. Cornelius, C. Mancuso, R. Lentile, A.M. Stella, and D.A. Butterfield, "Redox Homeostasis and Cellular Stress Response in Aging and Neurodegeneration," Meth. Molec. Biol. 610, 285-308 (2010).

465. D.A. Butterfield, V. Galvan, M. Bader Lange, H. Tang, R.A. Sowell, P. Spilman, J. Fombonne, O. Gorostiza, J. Zhang, R. Sultana, and D.E. Bredesen, "In Vivo Oxidative Stress in Brain of Alzheimer Disease Transgenic Mice: Requirement for Methionine 35 in Amyloid β-Peptide of APP," (2010).

464. T.T. Reed, R. Sultana, and D.A. Butterfield, “Redox Proteomics of Oxidatively Modified Brain Proteins in Mild Cognitive Impairment,” in (2010).

463. R. Sultana and D.A. Butterfield., “Role of Oxidative Stress in the Progression of Alzheimer's Disease,”(2010).>

462. V. Calabrese, R. Lentile, C. Cornelius, M. Scalia, M.T. Cambria, B. Ventimiglia, G. Pennisi, C. Mancuso, and D.A. Butterfield, “Nutritional redox homeostasis and cellular stress response: differential role of homocysteine and acetylcarnitine,” Oxid. Stress Dis., 25, 229-250 (2009).

461. D.A. Butterfield and H. Mohmmad Abdul, "Lipids in Alzheimer's Disease Brain," in (2009).

460. T.T. Reed, W.M. Pierce Jr., D.M. Turner, W.R. Markesbery, and D.A. Butterfield, “Proteomic Identification of Nitrated Brain Proteins in Early Alzheimer’s Disease Inferior Parietal Lobule,” (2009).

459. R. Sultana and D.A. Butterfield, “Oxidatively Modified, Mitochondria-Relevant Brain Proteins in Subjects with Alzheimer Disease and Mild Cognitive Impairment,” (2009).

458. V. Calabrese, C. Cornelius, E. Rizzarelli, J.B. Owen, A.T. Dinkova-Kostova, and D.A. Butterfield, "Nitric Oxide in Cell Survival: A Janus Molecule," (2009).

457. D.A. Butterfield and M.L. Bader Lange, “Multifunctional Roles of Enolase in Alzheimer Disease Brain: Beyond Altered Glucose Metabolism,” (2009).

456. R.A. Sowell, C.D. Aluise, and D.A. Butterfield, "Acetyl-L-Carnitine and Ferulic Acid Action in Aging and Neurodegenerative Diseases," in (2009).

455. R. Sultana and D.A. Butterfield, “Proteomics Identification of Carbonylated and HNE-Bound Brain Proteins in Alzheimer’s Disease,” (2009).

454. R.A. Yokel, R.L. Florence, J.M. Unrine, M.T. Tseng, U.M. Graham, P. Wu, E.A. Grulke, R. Sultana, S.S. Hardas, and D.A. Butterfield, “Biodistribution and Oxidative Stress Effects of a Systemically-Introduced Commercial Ceria Engineered Nanomaterial,” (2009).

453. R. Sultana, R.A. Sowell, and D.A. Butterfield, “Nitrated Proteins in the Progression of Alzheimer’s Disease: A Proteomics Comparison of Mild Cognitive Impairment and Alzheimer’s Disease Brain,” in (2009).

452. R. Sultana, M. Perluigi, and D.A. Butterfield, "Proteomics Identification of Oxidatively Modified Proteins in Brain,” in (2009).

451. C.D. Aluise, D. St. Clair, M. Vore, and D.A. Butterfield, “In Vivo Amelioration of Doxorubicin Induced Oxidative Stress in Plasma by Gamma-Glutamylcysteine Ethyl Ester (GCEE),” (2009).

450. R. Sultana, T. Reed, and D.A. Butterfield, “Detection of 4-Hydroxy-2-Nonenal- and 3-Nitrotyrosine-Modified Proteins Using a Proteomics Approach,” Methods Molec. Biol. 519, 351-361 (2009).<

449. R. Sultana, M. Perluigi, and D.A. Butterfield, “Oxidatively Modified Proteins in Alzheimer's Disease, Mild Cognitive Impairment and Animal Models of AD: Role of Abeta in Pathogenesis," (2009).

448. M. Perluigi, R. Sultana, G. Cenini, F. Di Domenico, M. Memo, W.M. Pierce, R. Coccia, and D.A. Butterfield, "Redox Proteomics Identification of 4-Hydroxynonenal-Modified Brain Proteins in Alzheimer's Disease: Role of Lipid Peroxidation in Alzheimer's Disease Pathogenesis,"(2009).

447. T.T. Reed, W.M. Pierce, W.R. Markesbery, and D.A. Butterfield, “Proteomic Identification of HNE-bound Proteins in Early Alzheimer’s Disease: Insights into the Role of Lipid Peroxidation in the Progression of AD,” (2009).

446. P. Jungsuwadee, R. Nitipongvanitch, Y. Chen, L. Chaiswing, T.D. Oberly, D.A. Butterfield, D.K. St. Clair, and M. Vore, "Mrp1 Localization and Function in Cardiac Mitochondria after Doxorubicin," (2009).

445. L.B. Jaeger, S. Dohgu, R. Sultana, J.L. Lynch, J.B. Owen, M.A. Erickson, G.N. Shar, T.O. Price, M.A. Fleegal-Demotta, D.A. Butterfield, and W.A. Banks, “Lipopolysaccaride Alters the Blood-Brain Transport of Amyloid β-Protein: A Mechanism for Inflammation in the Progression of Alzheimer’s Disease,” (2009).

444. F. Di Domenico, M. Perluigi, C. Foppoli, C. Blarzino, R. Coccia, F.D. Marco, D.A. Butterfield, and C. Cini, “Protective effect of ferulic acid ethyl ester against oxidative stress mediated by UVB irradiation in human epidermal melanocytes,” (2009).

443. M.A. Ansari, H. Mohmmad Abdul, G. Joshi, W.O. Opii, and D.A. Butterfield, “Protective Effect of Quercetin in Primary Neurons Against Ab(1-42): Relevance to Alzheimer's Disease,” (2009).

442. F. Di Domenico, G. Cenini, R. Sultana, M. Perlugi, D. Uberti, M. Memo, and D.A. Butterfield, "Glutathionylation of the Pro-apoptotic Protein p53 in Alzheimer's Disease Brain: Implications for AD Pathogenesis," (2009).

441. L.R. Ribeiro, M.R. Fighera, M.S. Oliveira, A.F. Furian, L.M. Rambo, A.P. de Oliveira Ferreira, A.L. Lopes Saraiva, M.A. Souza, F.D. Lima, D.V. Magni, R. Dezengrini, E.F. Flores, D.A. Butterfield, J. Ferreira, A.R. Soares dos Santos, C.F. Mello, and L.F. Freire Royes, “Methylmalonate-induced Seizures Are Attenuated in Inducible Nitric Oxide Synthase Knockout Mice,” (2009).

440. J. Owen, F. Di Domenico, R. Sultana, M. Perluigi, C. Cini, W. Pierce, and D.A. Butterfield, “Proteomics-Determined Differences in the Concanavalin-A Fractionated Proteome of Hippocampus and Inferior Parietal Lobule in Subjects with Alzheimer’s Disease and Mild Cognitive Impairment: Implications for Progression of AD," (2009).

439. T.T. Reed, J. Owen, W.M. Pierce, A. Sebastian, P.G. Sullivan, and D.A. Butterfield, "Proteomic Identification of Nitrated Brain Proteins in Traumatic Brain Injured Rats Treated Post-Injury with Gamma-Glutamylcysteine Ethyl Ester: Insights into the Role of Glutathione Elevation as a Potential Therapeutic Strategy for Traumatic Brain Injury," (2009).

438. R.A. Sowell, J.B. Owen, and D.A. Butterfield, "Proteomics in Animal Models of Alzheimer's and Parkinson's Diseases," (2009).

437. D.A. Butterfield and W.O. Opii, "Mitochondrial Dysfunction in Nervous System Injury," in The New Encyclopedia of Neuroscience, L. Squire, T. Albright, F. Bloom, F. Gage and N. Spitzer, Eds., Elsevier, Oxford, (2009).

436. M. Perluigi, A. Giorgi, C. Blarzino, F. De Marco, C. Foppoli, F, Di Domenico, D.A. Butterfield, M.E. Schininà, C. Cini, and R. Coccia, “Proteomics Analysis of Protein Expression and Specific Protein Oxidation in Human Papillomavirus Transformed Keratinocytes Upon UVB Irradiation,” (2009).

435. R. Sultana and D.A. Butterfield, “Redox Proteomics Analysis of Oxidative Modified Brain Proteins in Alzheimer’s Disease and Mild Cognitive Impairment: Insights into the Progression of this Dementing Disorder,” (2008).

434. R. Sultana, H.F. Poon, and D.A. Butterfield, "Redox Proteomics Identification of Oxidatively Modified Proteins in Alzheimer's Disease Brain and in Brain From a Rodent Model of Familial Parkinson's Disease,” (2008).

433. V. Calabrese, D.A. Butterfield, and A.M. Stella, "Aging and Oxidative Stress Response in the CNS,” (2008).

432. V. Calabrese, R. Ientile, C. Mancuso, A.M. Giuffrida Stella, and D.A. Butterfield, "Nutritional Redox Homeostasis and Cellular Stress Response: Differential Role of Homocysteine and Acetylcarnitine," in Dietary Modulation of Cell Signaling Pathways, (Y.J. Surh, Z. Dong, E. Cadenas, and L. Packer, Eds.), CRC Press, Boca Raton, FL, pp. 230-250 (2008).

431. V. Calabrese, C. Mancuso, C. Cornelius, M.S. Calafato, D.A. Butterfield, A.T. Kinkova-Kostova, and E. Rizzarelli, “Reactive Nitrogen Species and Cellular Stress Tolerance in Aging and Neurodegeneration: Role of Vitagenes,” in Free Radical Pathophysiology, (S. Alvarez and P. Evelson, eds.) Transworld Research Network, Kerala, India, pp. 345-367 (2008).

430. V. Calabrese, G. Pennisi, M. Calvani, D.A. Butterfield, and C. Mancuso, "Heme Oxygenase as Therapeutic Funnel in Nutritional Redox Homeostasis and Cellular Stress Response: Role of Acetylcarnitine," in Heat Shock Proteins in Neural Cells, Ed. by C. Richter-Landsberg, Elsevier Press, Amsterdam, pp. 39-52 (2008).

429. R. Sultana, S.F. Newman, Q. Huang, and D.A. Butterfield, “Detection of Carbonylated Proteins In Two-Dimensional Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis Separations,” (2008).

428. D.A. Butterfield, “An Overview of Biofunctional Membranes for Tunable Separations, Metal-ion Capture, and Enzyme Catalysis Based on Research From the Laboratories of Allan Butterfield and Dibakar Bhattacharyya,” (2008).

427. R. Sultana, M. Piroddi, F. Galli, and D.A. Butterfield, "Protein Levels and Activity of Some Antioxidant Enzymes in Hippocampus of Subjects with Amnestic Mild Cognitive Impairment and Age-Matched Controls," (2008).

426. J.B. Owen, W.O. Opii, C. Ramassamy, W.M. Pierce, and D.A. Butterfield, “Proteomic Analysis of Brain Protein Expression Levels in NF-k-B p50 -/+ Homozygous Knockout Mice,” (2008).

425. H. Mohmmad Abdul, R. Sultana, D.K. St. Clair, W.R. Markesbery, and D.A. Butterfield, "Oxidative Damage in Brain From Human Mutant APP/PS-1 Double Knock-In Mice as a Function of Age," (2008).

424. C.D. Aluise, R.A. Sowell, and D.A. Butterfield, “Peptides and Proteins in Plasma and Cerebrospinal Fluid as Biomarkers for the Prediction, Diagnosis, and Monitoring of Therapeutic Efficacy of Alzheimer's Disease,” (2008).

423. G. Cenini, R. Sultana, M. Memo, and D.A. Butterfield, “Effects of Oxidative and Nitrosative Stress in Brain on p53 Proapoptotic Protein in Amnestic Mild Cognitive Impairment and Alzheimer Disease,” (2008).

422. R. Sultana, S.F.Newman, and D.A.Butterfield "Redox Proteomics: Applications to Age-Related Neurodegenerative Disorders," in Proteomics of the Nervous System, H.G. Nothwang and S.E. Pfeiffer, Eds., Wiley-VCH Verlag GmbH & Co., Weinheim, Germany, pp. 253-269 (2008).

421. C. Cenini, R. Sultana, M. Memo, and D.A. Butterfield,“Elevated Levels of p53 and Its Oxidative Modification by HNE in Brain From Subjects with Mild Cognitive Impairment and Alzheimer’s Disease,” (2008).

420. R. Sultana and D.A. Butterfield, "Redox Proteomics Studies of In Vivo Amyloid Beta-Peptide Animal Models of Alzheimer's Disease: Insight into the Role of Oxidative Stress," (2008).

419. D.A. Butterfield and R. Sultana, "Redox Proteomics: Understanding Oxidative Stress in the Progression of Age-Related Neurodegenerative Disorders," (2008).

418. E.G. Oesterling, C. Nitin, X. Arzuaga, D.A. Butterfield, L.G. Bachas, and B. Hennig, “Alumina Nanoparticles Induce Expression of Endothelial Cell Adhesion Molecules,” (2008).

417. P. Sompol, W. Ittarat, J. Tangpong, Y. Chen, I. Doubinskaia, I. Batinic-Haberle, H. Mohmmad Abdul, D.A. Butterfield, and D.K. St. Clair, “A Neuronal Model of Alzheimer’s Disease: An Insight into the Mechanisms of Oxidative Stress-Mediated Mitochondrial Injury,” (2008).

416. S.A. Farr, K.A. Yamada, D.A. Butterfield, H. Mohmmad Abdul, L. Xu, N.E. Miller, W.A. Banks, and J.E. Morley, “Obesity and Hypertriglyceridemia Produce Cognitive Impairment,” (2008).

415. V. Calabrese, C. Mancuso, R. Ientile, A.M. Giuffrida Stella, and D.A. Butterfield, "Redox Homeostasis and Cellular Stress Response in Aging and Neurodegeneration," in Free Radicals in Biology and Medicine, Y.-J Surh, Z. Dong, E. Cadenas, and L. Packer, Eds., CRC Press, Boca Raton, FL, pp. 229-249 (2008).

414. P. Mecocci, E. Mariani, M.C. Polidori, K. Hensley, and D.A. Butterfield, “Antioxidant Agents in Alzheimer’s Disease,” Central Nervous System Agents in Medicinal ��vlog�ٷ�� 8, 48-63 (2008).

413. M.A. Brito, S. Lima, A. Fernandes, A.S. Falcao, R.F. Silva, D.A. Butterfield, and D. Brites, “Bilirubin Injury to Neurons: Contribution of Oxidative Stress and Rescue by Glycoursodeoxycholic Acid,” (2008).

412. T. Reed, M. Perluigi, R. Sultana, W.M. Pierce, D.M. Turner, R. Coccia, W.R. Markesbery, and D.A. Butterfield, “Redox Proteomic Identification of 4-Hydroxy-2-Nonenal-Modified Proteins in Amnestic Mild Cognitive Impairment: Insight into the Role of Lipid Peroxidation in the Progression and Pathogenesis of Alzheimer’s Disease,” (2008).

411. M.L. Bader Lange, G. Cenini, M. Piroddi, H. Mohmmad Abdul, R. Sultana, F. Galli, M. Memo, and D.A. Butterfield, “Loss of Phospholipid Asymmetry and Elevated Protein Levels in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer’s Disease,” (2008).

410. R. Sultana, T. Reed, and D.A. Butterfield, "Redox Proteomics and Metabolic Proteins in Brain of Subjects with Alzheimer’s Disease, Mild Cognitive Impairment, and Models Thereof," in (2008).

409. R. Sultana and D.A. Butterfield, “Slot Blot Analysis of 3-Nitrotyrosine-Modified Brain Proteins,” (2008).

408. D.A. Butterfield and R. Sultana, “Identification of 3-Nitrotyrosine-Modified Brain Proteins by Redox Proteomics,” (2008).

407. J. Tangpong, P. Sompol, M. Vore, W. St. Clair, D.A. Butterfield, and D.K. St. Clair, “Tumor Necrosis Factor Alpha-Mediated Nitric Oxide Production Enhances Maganese Superoxide Dismutase Nitration and Mitochondrial Dysfunction in Primary Neurons: An Insight into the Role of Glial Cells,” (2008).

406. M.A. Brito, A.I. Rosaa, A.S. Falcaoa, A. Fernandesa, F. Rui, M. Silvaa, D.A. Butterfield, and D. Brites, "Unconjugated Bilirubin Differentially Affects the Redox Status of Neuronal and Astroglial Cells," (2008).

405. R. Sultana and D.A. Butterfield, “Alterations of Some Membrane Transport Proteins in Alzheimer’s Disease: Role of Amyloid Beta-Peptide,” (2008).

404. W. O. Opii, G. Joshi, E. Head, N. W. Milgram, B. A. Muggenburg, J. B. Klein, W. M. Pierce, C. W. Cotman, and D.A. Butterfield, "Proteomic Identification of Brain Proteins in the Canine Model of Human Aging Following a Long-Term Treatment with Antioxidants and Program of Behavioral Enrichment: Relevance to Alzheimer's Disease," (2008).

403. D.A. Butterfield, "Oxidative Modification of Brain Proteins in Alzheimer's Disease and Models Thereof: Role of Amyloid Beta-Peptide (1- 42) and Insights From Redox Proteomics ", in Davies, K. (ed.), Free Radicals and the Oxygen Paradox: Oxidative Stress in Biology, Aging and Disease, The Biomedical & Life Sciences Collection, Henry Stewart Talks Ltd, London (2007). On Line version (first 5-minutes):

402. H.F. Poon, N.A. Shreve, A. Veicsteinas, V. Calabrese, F. Esposito, and D. A. Butterfield, “Exercise-Mediated Alteration of Protein Redox State in Plasma: A Possible Stimulant for Hermetic Response,” (2007).

401. D.A. Butterfield and R. Sultana, “Proteomics Analysis in Alzheimer’s Disease: New Insights into Mechanisms of Neurodegeneration,” (2007).

400. C. Mancuso, T. E. Bates, D.A. Butterfield, S. Calafato, C. Cornelius, A.T. Dinkova Kostova, and V. Calabrese, “Natural Antioxidants in Alzheimer’s Disease,” Expert Opinion in Investigational Drugs 16, 1921-1931 (2007).

399. V. Calabrese, C. Mancuso, M. Calvani, E. Rizzarelli, D.A. Butterfield, and A.M. Giuffrida Stella, “Nitric Oxide in the Nervous System: Neuroprotection vs. Neurotoxicity,” (2007).

398. D.A. Butterfield and R. Sultana, “Redox Proteomics Identification of Oxidatively Modified Brain Proteins in Alzheimer’s Disease and Mild Cognitive Impairment: Insights into the Progression of this Dementing Disorder,” Journal of Alzheimer’s Disease 12, 61-72 (2007).

397. R. Sultana, T. Reed, M. Perluigi, R. Coccia, W.M. Pierce, and D.A. Butterfield, “Proteomic Identification of Nitrated Brain Proteins in Amnestic Mild Cognitive Impairment: A Regional Study,” (2007).

396. D.A. Butterfield, Tanea Reed, Shelley F. Newman, and Rukhsana Sultana, “Roles of Amyloid β-Peptide-Associated Oxidative Stress and Brain Protein Modifications in the Pathogenesis of Alzheimer’s Disease and Mild Cognitive Impairment,”(2007).

395. C. F. Mello, R. Sultana, M. Piroddi, J. Cai, W. M. Pierce, J.B. Klein, and D.A. Butterfield, "Acrolein Induces Selective Protein Carbonylation in Synaptosomes," (2007).

394. Y. Chen, P. Jungsuwadee, M. Vore, D.A. Butterfield, and D.K. St. Clair, "Collateral Damage in Cancer Chemotherapy: Oxidative Stress in Nontargeted Tissues," (2007).

393. R. Sultana and D.A. Butterfield, "Redox Proteomics Analysis of Oxidatively Modified Brain Proteins in Alzheimer's Disease and Mild Cognitive Impairment: Insights into the Progression of this Dementing Disorder," in (2007).

392. W. Opii, V. Nukala, R. Sultana, J. Pandya, K. Day, M. Merchant, J. Klein, P. Sullivan, and D.A. Butterfield, “Proteomic Identification of Oxidized Mitochondrial Proteins Following Experimental Brain Injury,” (2007).

391. R. Sultana, D. Boyd-Kimball, J. Cai, W.M. Pierce, J.B. Klein, M. Merchant, and D.A. Butterfield, “Proteomics Analysis of the Alzheimer’s Disease Hippocampal Proteome,” (2007).

390. M. Piroddi, I. Depunzio, V. Calabrese, C. Mancuso, C.M. Aisa, L. Binaglia, A. Minelli, D.A. Butterfield, and F. Galli, “Oxidatively-Modified and Glycated Proteins as Candidate Pro-Inflammatory Toxins in Uremia and Dialysis Patients,” (2007).

389. V. Calabrese, E. Guagliano, M. Sapienza, M. Panebianco, S. Calafato, E. Puleo, G. Pennisi, C. Mancuso, D.A. Butterfield, and A. M. Giuffrida Stella, "Redox Regulation of Cellular Stress Response in Aging and Neurodegenerative Disorders: Role of Vitagenes," (2007).

388. R. Sultana and D.A. Butterfield, "Regional Expression of Key Cell Cycle Proteins in Brain From Subjects with Amnestic Mild Cognitive Impairment," (2007).

387. S. Newman, R. Sultana, M. Perluigi, R. Coccina, J. Cai, W. Pierce, J. Klein, and D.A. Butterfield, “An Increase in S-Glutathionylated Proteins in the Alzheimer’s Disease Inferior Parietal Lobule, a Proteomics Approach,” (2007).

386. V. Calabrese, C. Mancuso, G. Scapagnini, A. Ravagna, M. Perluigi, C. Cini, C. De Marco, D.A. Butterfield, and A. M. Giuffrida Stella, "In Vivo Induction of Heat Shock Proteins in the Substantia Nigra Following L-DOPA Administration is Associated with Increased Activity of Mitochondrial Complex I and Nitrosative Stress in the Rat: Regulation by Glutathione Redox State," (2007).

385. D.A. Butterfield , T. Reed, M. Perluigi, Carlo De Marco, Raffaella Coccia, J,N. Keller, W.R. Markesbery, and R. Sultana, “Elevated Levels of 3-Nitrotyrosine in Brain From Subjects with Amnestic Mild Cognitive Impairment: Implications for the Role of Nitration in the Progression of Alzheimer’s Disease,” (2007).

384. C.F. Mello, M.A. Rubin, R. Sultana, S. Barron, J.M. Littleton, and D.A. Butterfield, "Difluoromethylornithine (DFMO) Prevents Protein Oxidation Induced by Neonatal Ethanol Exposure in the Hippocampus of Young Rats," (2007).

383. W.O. Opii, R. Sultana, H. Mohmmad Abdul, M. Ansari, A. Nath, and D.A. Butterfield, "Oxidative Stress and Toxicity Induced by the Nucleoside Reverse Transcriptase Inhibitor (NRTI) - 2',3'-Dideoxycytidine (ddC): Relevance to HIV Dementia," (2007).

382. D.A. Butterfield, “Amyloid β-Peptide (1-42), Oxidative Stress and Alzheimer’s Disease,” (2007).

381. R. Vaishnau, M. Gatchell, H.F.Poon, K. Barnett, S. Hunter, W. Pierce, J.B Klein, D.A. Butterfield, and T. Getchell, "Oxidative Stress in the Aging Murine Olfactory Bulb: Redox Proteomics and Cellular Localization," (2007).

380. G. Joshi, S. Hardas, R. Sultana, M. Vore, D. St. Clair, and D.A. Butterfield, "Glutathione Elevation by Gamma-Glutamylcysteine Ethyl Ester as a Potential Therapeutic Strategy Towards Preventing Oxidative Stress in Brain Mediated by In Vivo Administration of Adriamycin: Implications for Chemobrain," (2007).

379. H. Mohmmad Abdul and D.A. Butterfield, "Involvement of PI3K/PKG/ERK1/2 Signaling Pathways in Cortical Neurons to Trigger Protection by Co-treatment of Acetyl-L-Carnitine and Alpha-Lipoic Acid Against HNE-Mediated Oxidative Stress and Neurotoxicity: Implications for Alzheimer's Disease," Free Radic. Biol. Med. 42, 371-384 (2007).

378. J. Tangpong, M. P. Cole, R. Sultana, S. Estus, M. Vore, W. St. Clair, S. Ratanachaiyavong, D.K. St. Clair, and D.A. Butterfield, "Adriamycin Mediated Nitration of Manganese Superoxide Dismutase in the Central Nervous System: Insight into the Mechanism of Chemobrain," (2007).

377. C. Mancuso, G. Scapagnini, D. Gurro, A.M. Giuffrida Stella, C. De Marco, D.A. Butterfield, and V. Calabrese. “Mitochondrial Dysfunction, Free Radical Generation and Cellular Stress Response in Neurodegenerative Disorders,” (2007).

376. V. Calabrese, C. Mancuso, C. De Mello, A.M. Gifffrida Stella, and D.A. Butterfield, "Nitric Oxide and Cellular Stress Response in Brain Aging and Neurodegenerative Disorders," in Oxidative Stress and Neurological Disorders, G. A. Qureshi and S. Hassan Parvez, Eds., Elsevier Publishers, Amsterdam, 2007, pp. 115-134.

375. P.A. Crooks, S. G. Kottayil, A.M. Al-Ghananeem, S.R. Bryn, and D.A. Butterfield, "Opiate Receptor Binding Properteis of Morphine-, Dihydromorphine-, and Codeine 6-O-Sulfate Ester Congeners," (2006).

374. V. Calabrese, E. Guagliano, M. Sapienza, C. Mancuso, D.A. Butterfield, and A.M. Stella, “Redox Regulation of Cellular Stress Response in Neurodegenerative Disorders,” Italian J. Biochem. 55, 263-282 (2006).

373. D.A. Butterfield, A. Gnjec, H.F. Poon, A. Castegna, W.M. Pierce, J.B. Klein, and R.N. Martins, "Redox Proteomics Identification of Oxidatively Modified Brain Proteins in Inherited Alzheimer's Disease: An Initial Assessment," (2006).

372. V. Smuleac, D.A. Butterfield, and D. Bhattacharyya, "Layer-by-Layer Assembled Microfiltration Membranes for Biomolecule Immobilization and Enzymatic Catalysis," (2006).

371. P. Jungsuwadee, M. P. Cole, R. Sultana, G. Joshi, J. Tanpong, D.A. Butterfield, D.K. St. Clair, and M. Vore, "Increase in Mrp1 Expression and HNE Adduction in Heart Tissue of Adriamycin-Treated C57BL/6 Mice," (2006).

370. M.A. Ansari, G. Joshi, Q. Huang, W.O. Opii, H. Mohmmad Abdul, R. Sultana, and D.A. Butterfield, "In Vivo Administration of D609 Leads to Protection of Subsequently Isolated Gerbil Brain Mitochondria Subjected to In Vitro Oxidative Stress Induced by Amyloid Beta-Peptide and Other Oxidative Stressors: Relevance to Alzheimer's Disease and Other Oxidative Stress-Related Neurodegenerative Disorders," (2006).

369. Y. Chen, C. Daosukho, W.O. Opii, D.N. Turner, W.M. Pierce, J.B. Klein, M. Vore, D.A. Butterfield, and D.K. St. Clair, "Redox Proteomics Identification of Oxidized Cardiac Proteins in Adriamycin-Treated Mice," (2006).

368. R. Sultana, D. Boyd-Kimball, H.F. Poon, J. Cai, W. M. Pierce, J.B. Klein, M. Merchant, W.R. Markesbery, and D.A. Butterfield, "Redox Proteomics Identification of Oxidized Proteins in Alzheimer's Disease Hippocampus and Cerebellum: An Approach to Understand Pathological and Biochemical Alterations in AD," (2006).

367. J. Steiner, N. Haughey, W. Li, A. Venkatesan, C. Anderson, R. Reid, T. Malpica1, C. Pocernich, D.A. Butterfield, and A. Nath, "Oxidative Stress and Therapeutic Approaches in HIV Dementia," (2006).

366. R. Sultana, M. Perluigi, and D.A. Butterfield, "Protein Oxidation and Lipid Peroxidation in Brain of Subjects with Alzheimer’s Disease: Insights into Mechanism of Neurodegeneration From Redox Proteomics," (2006).

365. V. Calabrese, R. Sultana, G. Scapagnini, E. Guagliano, M. Sapienza, R. Bella, J. Kanski, G. Pennisi, C. Mancuso, A.M. Giuffrida Stella, and D.A. Butterfield, "Nitrosative Stress, Cellular Stress Response, and Thiol Homeostasis in Patients with Alzheimer’s Disease," (2006).

364. D.A. Butterfield, "Oxidative Stress in Neurodegenerative Disorders," (2006).

363. D.A. Butterfield, H. Mohmmad Abdul, W. Opii, S.F. Newman, G. Joshi, M. A., Ansari, and R. Sultana, "Pin1 in Alzheimer's Disease," (2006).

362. D.A. Butterfield, M. Perluigi, and R. Sultana, "Oxidative Stress in Alzheimer's Disease Brain: New Insights From Redox Proteomics," (2006).

361. D.A. Butterfield and R. Sultana, "Redox Proteomics Analysis of Oxidatively Modified Brain Proteins in Alzheimer's Disease," in .

360. M. Perluigi, G. Joshi, R. Sultana, V. Calabrese, C. De Marco, R. Coccia, C. Cini, and D.A. Butterfield, "In Vivo Protective Effects of Ferulic Acid Ethyl Ester Against Amyloid β-Peptide (1-42)-Induced Oxidative Stress," (2006).

359. R. Sultana, S.F. Newman, H. Mohmmad-Abdul, J. Cai, W.M. Pierce, J.B. Klein, M. Merchant, and D.A. Butterfield, "Protective Effect of D609 Against Ab(1-42)-Induced Oxidative Modification of Neuronal Proteins: Redox Proteomics Study," (2006).

358. H. Mohmmad-Abdul, V. Calabrese, M. Calvani, and D.A. Butterfield, "Acetyl-L-Carnitine-Induced Up-Regulation of Heat Shock Proteins Protects Cortical Neurons Against Amyloid-Beta Peptide 1-42-Mediated Oxidative Stress and Neurotoxicity: Implications for Alzheimer's Disease," (2006).

357. D. Boyd-Kimball, H.F.Poon, B.C. Lynn, J. Cai, W.M. Pierce, Jr., J.B. Klein, J.Ferguson, C.D. Link, and D.A. Butterfield, "Proteomic Identification of Proteins Specifically Oxidized in Caenorhabditis elegans Expressing Human Ab(1-42): Implications for Alzheimer's Disease," (2006).

356. D.A. Butterfield, H. Mohmmad Abdul, S. Newman, and T. Reed, "Redox Proteomics in Some Age-Related Neurodegenerative Disorders or Models Thereof," (2006).

355. S.J. Chinta, S. Rajagopalan, D.A. Butterfield, and J.K. Andersen, "In Vitro and In Vivo Neuroprotection by (-Glutamylcysteine Ethyl Ester Against MPTP: Relevance to the Role of Glutathione in Parkinson's Disease," (2006).

354. J. Tangpong, M.P. Cole, R. Sultana, G. Joshi, S. Estus, M. Vore, W. St. Clair, S. Ratanachaiyavong, D. St. Clair, and D.A. Butterfield, "Adriamycin-Induced, TNF-a"-Mediated Central Nervous System Toxicity," (2006).

353. K.A. Langer, H.F. Poon, G. Munch, B.C. Lynn, T. Arendt, and D.A. Butterfield, "Identification of AGE-Modified Proteins in SH-SY5Y and OLN-93 Cells," (2006).

352. H.F. Poon, H.M. Shepherd, T.T. Reed, V. Calabrese, A.M. Giuffrida-Stella, G. Pennisi, J. Cai, W.M. Pierce, J.B. Klein, and D.A. Butterfield, "Proteomics Analysis Provides Insight into Caloric Restriction Mediated Oxidation and Expression of Brain Proteins Associated with Age-Related Impaired Cellular Processes: Mitochondrial Dysfunction, Glutamate Dysregulation and Impaired Protein Synthesis," (2006).

351. H.F. Poon, R.A. Vaishnav, T.V. Getchell, M.L. Getchell, and D.A. Butterfield, "Quantitative Proteomics Analysis of Differential Protein Expression and Oxidative Modification of Specific Proteins in the Brains of Old Mice," (2006).

350. R. Sultana, D. Boyd-Kimball, H.F. Poon, J. Cai, W.M. Pierce, J.B. Klein, W.R. Markesbery, X.Z. Zhou, K.P. Lu, and D.A. Butterfield, "Oxidative Modification and Down-Regulation of Pin 1 in Alzheimer's Disease Hippocampus: A Redox Proteomics Analysis," (2006).

349. V. Calabrese, C. Colombrita R. Sultana, G. Scapagnini, M. Calvani, and D.A. Butterfield , "Redox Modulation of Heat Shock Protein Expression by Acetylcarnitine in Aging Brain: Relationship to Antioxidant Status and Mitochondrial Function," (2006).

348. H.F. Poon, V. Calabrese, M. Calvani, and D.A. Butterfield , "Proteomics Analyses of Specific Protein Oxidation and Protein Expression in Aged Rat Brain and Its Modulation by L-Acetylcarnitine: Insights into the Mechanisms of Action of this Proposed Therapeutic Agent for CNS Disorders Associated with Oxidative Stress," (2006).

347. D.A. Butterfield , H.F. Poon, D. St. Clair, J.N. Keller, W.M. Pierce, J.B. Klein, and W.R. Markesbery, "Redox Proteomics Identification of Oxidatively Modified Hippocampal Proteins in Mild Cognitive Impairment: Insights into the Development of Alzheimer's Disease," (2006).

346. R. Sultana, M. Perluigi, and D.A. Butterfield , "Redox Proteomics Identification of Oxidatively Modified Proteins in Alzheimer's Disease Brain and In Vivo and In Vitro Models of AD Centered Around Ab(1-42)," (2006).

345. R. Sultana, H.F. Poon, J. Cai, W.M. Pierce, M. Merchant, J.B. Klein, W.R. Markesbery, and D.A. Butterfield, "Identification of Nitrated Proteins in Alzheimer's Disease Brain Using a Redox Proteomics Approach," (2006).

344. V. Calabrese, D.A. Butterfield, G. Scapagnini, A.M. Giuffrida Stella, and M.D. Maines."Redox Regulation of Heat Shock Protein Expression by Signaling Involving Nitric Oxide and Carbon Monoxide: Relevance to Brain Aging, Neurodegenerative Disorders, and Longevity," (2006).

343. M. Perluigi, G. Joshi, R. Sultana, V. Calabrese, C. De Marco, R. Coccia, and D.A. Butterfield, " In Vivo Protection by the Xanthate D609 Against Amyloid β-Peptide (1-42)-Induced Oxidative Stress: Implications for Alzheimer's Disease," Neuroscience 138, 1161-1170 (2006).

342. D.A. Butterfield, T. Reed, M. Perluigi, C. De Marco, R. Coccia, C. Cini, and R. Sultana, "Elevated Protein-Bound Levels of the Lipid Peroxidation Product, 4-Hydroxy-2-Nonenal, in Brain From Persons with Mild Cognitive Impairment," (2006).

341. D. Ranjan, C. Chen, T.D. Johnston, H. Jeon, M. Ibrahim, J. Drake, and D.A. Butterfield, "Stimulation of Epstein-Barr Virus-Infected Human B Cell Growth by Physiological Concentrations of 4-Hydroxynonenal," (2006).

340. O. Bartov, R. Sultana, D.A. Butterfield, and D. Atlas, "Low Molecular Weight Thiol Amides Attenuate MAPK Activity and Protect Primary Neurons From Ab(1-42) Toxicity," (2006).

339. D.A. Butterfield, R. Sultana, and H. F. Poon, "Redox Proteomics: A New Approach to Investigate Oxidative Stress in Alzheimer's Disease," .

338. I. Dalle-Donne, A. Scaloni, and D.A. Butterfield, Eds., Redox Proteomics: From Protein Modifications to Cellular Dysfunction and Diseases , (2006).

337. H. Mohmmad-Abdul, R. Sultana, J.N. Keller, D.K. St. Clair, W.R. Markesbery, and D.A. Butterfield, "Mutations in Amyloid Precursor Protein and Presenilin-1 Genes Increase the Basal Oxidative Stress in Murine Neuronal Cells and Lead to Increased Sensitivity to Oxidative Stress Mediated by Amyloid β-Peptide (1-42), H 2O 2 and Kainic Acid: Implications for Alzheimer’s Disease," (2006).

336. G. Joshi, M. Perluigi, R. Sultana, R. Agrippino, V. Calabrese, and D.A. Butterfield, " In Vivo Protection of Synaptosomes by Ferulic Acid Ethyl Ester (FAEE) From Oxidative Stress Mediated by 2,2-Azobis (2-Amidino-propoane) Dihyrochloride (AAPH) or Fe 2+/H 2O 2: Insight into Mechanisms of Neuroprotection and Relevance to Oxidative Stress Related Neurodegenerative Disorders," (2006).

335. V. Calabrese, M. Calvani, A.M. Giuffrida Stella, and D.A. Butterfield, "Acetylcarnitine and Cellular Stress Response: Roles in Nutrition Redox Homeostasis and Regulation of Longevity Genes," (2006).

334. D.A. Butterfield, H.F. Poon, and R. Sultana, "Proteomic Identification of Oxidatively Modified Proteins in Alzheimer's Disease Brain and Models Thereof: Insights into Potential Mechanisms of Neurodegeneration," in (2006).

333. M. Perluigi, H.F. Poon, W. Maragos, W.M. Pierce, J.B. Klein, V. Calabrese, C. Cini, C. De Marco, and D.A. Butterfield, "Proteomic Analysis of Protein Expression and Oxidative Modification in R6/2 Transgenic Mice--A Model of Huntington's Disease," (2005).

332. G. Joshi, R. Sultana, J. Tangpong, M.P. Cole, D.K. St. Clair, M. Vore, S. Estus, and D.A. Butterfield, "Free Radical Mediated Oxidative Stress and Toxic Side Effects in Brain Induced by the Anti Cancer Drug Adriamycin: Insight into Chemobrain," (2005).

331. C.B. Pocernich, R. Sultana, H. Mohmmad Abdul, A. Nath, and D.A. Butterfield, "HIV-Dementia, Tat-Induced Oxidative Stress and Antioxidant Therapeutic Considerations," (2005).

330. D.A. Butterfield and H.F. Poon, "The Senescence-Accelerated Prone Mouse (SAMP8): A Model of Age-Related Cognitive Decline with Relevance to Alterations of the Gene Expression and Protein Abnormalities in Alzheimer's Disease," (2005).

329. V. Calabrese, C. Colombrita, E. Guagliano, M. Sapienza, A. Ravagna, V. Cardile, G. Scapagnini, A.M. Santoro, A. Mangiameli, D.A. Butterfield, A.M. Giuffrida Stella, and E. Rizzarelli, "Protective Effect of Carnosine During Nitrosative Stress in Astroglial Cell Cultures," (2005).

328. Y. Zhu, G. Jones, S. Tsutsui, W. Opii, S. Liu, C. Silva, D.A. Butterfield, and C. Power, "Lentivirus Infection Causes Neuroinflammation and Neuronal Injury in Dorsal Root Ganglia: Pathogenic Effects of STAT-1 and Inducible Nitric Oxide Synthase," (2005).

327. V. Calabrese, R. Lodi, C. Tonon, A. Ravagna, M. Sapienza, C. Colombrita, G. Scapagnini, and D.A. Butterfield, "Oxidative Stress, Mitochondrial Dysfunction, and Cellular Stress Response in Friedreich's Ataxia," (2005).

326. H.F. Poon, S.A. Farr, W.A. Banks, W.M. Pierce, J.B. Klein, J.E. Morley, and D.A. Butterfield, "Proteomic Identification of Brain Proteins in Aged Senescence Accelerated Mice That Have Decreased Oxidative Modification Following Administration of Antisense Oligonucleiotide Directed at the Ab Region of Amyloid Precursor Protein," (2005).

325. H.F. Poon, K. Hensley, V. Thongboonkerd, M.L. Merchant, B.C. Lynn, W.M. Pierce, J.B. Klein, V. Calabrese, and D.A. Butterfield, "Redox Proteomics Analysis of Oxidatively Modified Proteins in G93A-SOD1 Transgenic Mice-A Model of Familial Amyotrophic Lateral Sclerosis," (2005).

324. H.F. Poon, R.A. Vaishnav, D.A. Butterfield, M.L. Getchell, and T.V. Getchell, "Proteomic Identification of Differentially Expressed Proteins in the Aging Murine Olfactory System and Transcriptional Analysis of the Associated Genes," (2005).

323. H. Mohmmad Abdul, and D.A. Butterfield, "Protection Against Amyloid Beta-Peptide (1-42)-Induced Loss of Phospholipid Asymmetry in Synaptosomal Membranes by Tricyclodecan-9-xanthogenate (D609) and Ferulic Acid Ethyl Ester: Implications for Alzheimer's Disease," (2005).

322. D. Boyd-Kimball, A. Castegna, R. Sultana, H.F. Poon, R. Petroze, B.C. Lynn, J.B. Klein, and D.A. Butterfield, "Proteomic Identification of Proteins Oxidized by Ab(1-42) in Synaptosomes: Implications for Alzheimer's Disease," (2005).

321. V. Smuleac, D.A. Butterfield, S.K. Sikdar, R.S. Varma, and D. Bhattacharyya, "Polythiol Functionalized Alumina Membranes for Mercury Capture," (2005).

320. J.N. Keller, F.A. Schmitt, S.W. Scheff, Q. Ding, Q. Chen, D.A. Butterfield, and W.R. Markesbery, "Evidence of Increased Oxidative Damage in Subjects with Mild Cognitive Impairment," (2005).

319. D. Boyd-Kimball, R. Sultana, H.F. Poon, B.C. Lynn, F. Casamenti, G. Pepeu, J.B. Klien, and D.A. Butterfield, "Proteomic Identification of Proteins Specifically Oxidized by Intracerebral Injection of Ab(1-42) into Rat Brain: Implications for Alzheimer's Disease," (2005).

318. G. Joshi, R. Sultana, M. Perluigi, and D.A. Butterfield, " In Vivo Protection of Synaptosomes From Oxidative Stress Mediated by Fe 2+/H 2O 2 or 2,2-Azobis (2-amidinopropane) dihydrochloride (AAPH) by the Glutathione Mimetic Tricyclodecan-9-yl-xanthogenate (D609)," (2005).

317. H.F. Poon, M. Frasier, N. Shreve, V. Calabrese, B. Wolozin, and D.A. Butterfield, "Mitochondrial Associated Metabolic Proteins are Selectively Oxidized in A30P "a-Synuclein Mice - A Model of Familial Parkinson's Disease," (2005).

<>316. M. Perluigi, H.F. Poon, K. Hensley, W.M. Pierce, J.B. Klein, V. Calabrese, C. DeMarco, and D.A. Butterfield,"Proteomic Analysis of 4-Hydroxy-2-Nonenal-Modified Proteins in G93A-SOD1 Transgenic Mice - A Model of Familial Amytrophic Lateral Sclerosis," (2005).

315. D. Boyd-Kimball, R. Sultana, H. Mohmmad-Abdul, and D.A. Butterfield, "Neurotoxicity and Oxidative Stress in D1M-Substituted Alzheimer’s Ab(1-42): Relevance to N-Terminal Methionine ��vlog�ٷ�� in Small Model Peptides," (2005).

314. D. Boyd-Kimball, R. Sultana, H.F. Poon, H. Mohammad-Abdul, B.C. Lynn, J.B. Klein, and D.A. Butterfield, " (y-Glutamylcysteine Ethyl Ester Protection From Ab(1-42)-Mediated Oxidative Stress in Neuronal Cells: A Proteomics Approach," (2005).

313. D. Boyd-Kimball, R. Sultana, H. Mohammad-Abdul, and D.A. Butterfield, " y-Glutamylcysteine Ethyl Ester Induced Upregulation of Glutathione Protects Neurons Against Ab(1-42)-Mediated Oxidative Stress and Neurotoxicity: Implications for Alzheimer's Disease," (2005).

312. C.B. Pocernich, D. Boyd-Kimball, H.F. Poon, V. Thongboonkerd, B.C. Lynn, J.B. Klein, V. Calabrese, A. Nath, and D.A. Butterfield, "Proteomics Analysis of Human Astrocytes Expressing the HIV Protein Tat," (2005).

311. C.B. Pocernich, H.F. Poon, D. Boyd-Kimball, B.C. Lynn, A. Nath, J.B. Klein, and D.A. Butterfield, "Proteomics Analysis of Oxidatively Modifed Proteins Induced by the Mitochondrial Toxin 3-Nitropropionic Acid in Human Astrocytes Expressing the HIV Protein Tat," (2005).

310. V. Calabrese, A. Ravagna, C. Colombrita, E. Guagliano, G. Tomaselli, A.M. Giuffrida Stella, M. Calvani, and D.A. Butterfield, "Acetylcarnitine Induces Heme Oxygenase in Rat Astrocytes and Protects Against Oxidative Stress: Involvement of the Transcription Factor Nrf2," (2005).

309. R. Sultana, A. Ravagna, H. Mohmmad-Abdul, V. Calabrese, and D.A. Butterfield, "Ferulic Acid Ethyl Ester Protects Neurons Against Amyloid β-Peptide (1-42)-Induced Oxidative Stress and Neurotoxicity: Relationship to Antioxidant Activity," (2005).

308. D.A. Butterfield and D. Boyd-Kimball, "The Critical Role of Methionine 35 in Alzheimer's Amyloid β-Peptide (1-42)-Induced Oxidative Stress and Neurotoxicity," (2005).

307. H.F. Poon, S.A. Farr, V. Thongboonkerd, B.C. Lynn, W.A. Banks, J.E. Morley, J.B. Klein, and D.A. Butterfield, "Proteomic Analysis of Specific Brain Proteins in Aged SAMP8 Mice Treated with alpha-Lipoic Acid: Implications for Aging and Age-Related Neurodegenerative Disorders," (2005).

306. D. Boyd-Kimball, H. Mohmmad Abdul, T. Reed, R. Sultana, and D.A. Butterfield, "Role of Phenylalanine 20 in Alzheimer's Amyloid β-Peptide (1-42)-Induced Oxidative Stress and Neurotoxicity," (2004).

305. R. Sultana and D.A. Butterfield, "Oxidatively Modified GST and MRP1 in Alzheimer's Disease Brain: Implications for Accumulation of Reactive Lipid Peroxidation Products," (2004).

304. V. Calabrese, M. Calvani, and D.A. Butterfield, "Increased Formation of Short-Chain Organic Acids After Chronic Ethanol Administration and Its Interaction With the Carnitine Pool in Rat," (2004).

303. M. Brito, D. Brites, and D.A. Butterfield, "A Link Between Hyperbilirubinemia, Oxidative Stress, and Injury to Neocortical Synaptosomes," (2004).

302. D. Boyd-Kimball, R. Sultana, H. Mohmmad-Abdul, and D.A. Butterfield, "Rodent Ab(1-42) Exhibits Oxidative Stress Properties Similar to Those of Human Aβ(1-42): Implications for Proposed Mechanisms of Toxicity," (2004).

301. D.A. Butterfield and D. Boyd-Kimball, "Proteomics Analysis in Alzheimer's Disease: New Insights Into Mechanisms of Neurodegeneration," (2004).

300. D.A. Butterfield and D. Boyd-Kimball, "Amyloid β-Peptide(1-42) Contributes to the Oxidative Stress and Neurodegeneration Found in Alzheimer's Disease Brain," (2004).

299. H. Mohmmad Abdul, G.L. Wenk, M. Gramling, B. Hauss-Wegrzyniak, and D.A. Butterfield, "APP and PS-1 Mutations Induce Brain Oxidative Stress Independent of Dietary Cholesterol: Implications for Alzheimer's Disease," (2004).

298. J.M. Antony, G. van Marle, W. Opii,D.A. Butterfield, F. Mallet, V.W. Yong, J.L. Wallace, R.M. Deacon, K. Warren, and C. Power, "Human Endogenous Retrovirus Glycoprotein-Mediated Induction of Redox Reactants Causes Oligodendrocyte Death and Demyelination," (2004).

297. V. Smuleac, D.A. Butterfield, and D. Bhattacharyya, "Permeability and Separation Characteristics of Polypeptide Functionalized Polycarbonate Track-Etched Membranes," (2004).

296. V. Calabrese, A.M. Giuffrida Stella, D.A. Butterfield, and G. Scapagnini, "Redox Regulation in Neurodegeneration and Longevity: Role of Heme Oxgenase and HSP70 Systems in Brain Stress Tolerance," (2004).

295. H.F. Poon, G. Joshi, R. Sultana, S.A. Farr, W.A. Banks, J.E. Morley, V. Calabrese, and D.A. Butterfield, "Antisense Directed at the A b Region of APP Decreases Brain Oxidative Markers in Aged Senescence Accelerated Mice," (2004).

294. C.B. Pocernich, R. Sultana, E. Hone, J. Turchan, R.N. Martins, V. Calabrese, A. Nath, and D.A. Butterfield, "Effects of Apolipoprotein E on the Human Immunodeficiency Virus Protein Tat in Neuronal Cultures and Synaptosomes," (2004).

293. V. Calabrese, D. Boyd-Kimball, G. Scapagnini, and D.A. Butterfield, "Nitric Oxide and Cellular Stress Response in Brain Aging and Neurodegenerative Disorders: The Role of Vitagenes," (2004).

292. G. Scapagnini, D.A. Butterfield, C. Colombrita, R. Sultana, A. Pascale, and V. Calabrese, "Ethyl Ferulate, a Lipophilic Polyphenol, Induces HO-1 and Protects Rat Neurons Against Oxidative Stress," (2004).

291. H.F. Poon, A. Castegna, S.A. Farr, V. Thongboonkerd, B.C. Lynn, W.A. Banks, J.E. Morley, J.B. Klein, and D.A. Butterfield, "Quantitative Proteomics Analysis of Specific Protein Expression and Oxidative Modification in Aged SAMP8 Mouse Brain," (2004).

290. H.F. Poon, V. Calabrese, G. Scapagnini, and D.A. Butterfield, "Free Radicals in Brain Aging," (2004).

289. D.A. Butterfield and A.I. Bush, "Alzheimer's Amyloid β-Peptide (1-42): Involvement of Methionine Residue 35 in the Oxidative Stress and Neurotoxicity Properties of This Peptide," (2004).

288. D.A. Butterfield, "Oxidative Stress in Animal Models of Accelerated Aging, Alzheimer's Disease and Huntington's Disease," Frontiers of Medicinal ��vlog�ٷ�� 1, 385-397 (2004).

287. R. Sultana, S. Newman, H. Mohmmad-Abdul, J.N. Keller, and D.A. Butterfield, "Protective Effect of the Xanthate, D609, on Alzheimer's Amyloid β-Peptide (1-42)-Induced Oxidative Stress in Primary Neuronal Cells," (2004).

286. H.F. Poon, V. Calabrese, G. Scapagnini, and D.A. Butterfield, "Free Radicals: Key to Brain Aging and Heme Oxygenase as a Cellular Response to Oxidative Stress," (2004).

285. B. Downie, L.M.A. Dirk, Q. Xu, J. Drake, D. Zhang, M. Dutt, A. Levy, D.A. Butterfield, R.R. Geneve, J.W. Corum, III, K.G. Lindstrom, and J.C. Snyder, "A Physical, Enzymatic, and Genetic Characterization of Perturbations in the Seeds of the Brownseed Tomato Mutants," (2004).

284. W.F. Maragos, K.L. Young, C.S. Altman, C.B. Pocernich, J. Drake, D.A. Butterfield, I. Seif, D. P. Holschneider, K. Chen, and J. C. Shih, "Striatal Damage and Oxidative Stress Induced by the Mitochondrial Toxin Malonate are Reduced in Clorgyline-Treated Rats and MAO-A Deficient Mice," (2004).

283. D.A. Butterfield, "Insights into Mechanisms of Neurodegeneration," Innovation, 4, 46-47 (2004).

282. V. Calabrese, G. Scapagnini, A. Ravagna, C. Colombrita, F. Spadaro, D.A. Butterfield, and A.M. Giuffrida-Stella, "Increased Expression of Heat Shock Proteins in Rat Brain During Aging: Relationship with Mitochondrial Function and Glutathione Redox State," (2004).

281. A. Castegna, C.M. Lauderback, H. Mohmmad-Abdul, and D.A. Butterfield, "Modulation of Phospholipid Asymmetry in Synaptosomal Membranes by the Lipid Peroxidation Products, 4-Hydroxynonenal (HNE) and Acrolein: Implications for Alzheimer's Disease," (2004).

280. D.A. Butterfield, "Proteomics: A New Approach to Investigate Oxidative Stress in Alzheimer's Disease Brain," (2004).

279. J. Drake, R. Petroze, A. Castegna, Q. Ding, J.N. Keller, W.R. Markesbery, M.A. Lovell, and D.A. Butterfield, "4-Hydroxynonenal Oxidatively Modifies Histones: Implications for Alzheimer's Disease," (2004).

278. A. Castegna, V. Thongboonkerd, J. Klein, B.C. Lynn, Y.L. Wang, H. Osaka, K. Wada, and D.A. Butterfield, "Proteomic Analysis of Brain Proteins in the Gracile Axonaly Dystrophy (gad) Mouse, a Syndrome that Emanates From Dysfunctional Uquiquitin Carboxyl-Terminal Hydrolase L-1, Reveals Oxidation of Key Proteins," (2004).

277. D.A. Butterfield, "The Glutamatergic System in Alzheimer's Disease Brain: Dysfunction Associated with Amyloid β-Peptide and Oxidative Stress," in .

276. V. Calabrese, D.A. Butterfield, and A.M. Giuffrida-Stella, "Nutritional Antioxidants and the Heme Oxygenase Pathway of Stress Tolerance: Novel Targets for Neuroprotection in Alzheimer's Disease," Italian J. Biochem. 52, 177-181 (2003).

275. V. Calabrese, G. Scapagnini, C. Colombrita, A. Ravagna, G. Pennisi, A.M. Giuffrida-Stella, F. Galli, and D.A. Butterfield, "Redox Regulation of Heat Shock Protein Expression in Aging and Neurodegenerative Disorders Associated with Oxidative Stress: A Nutritional Approach," (2003).

274. J. Drake, R. Sultana, M. Aksenova, V. Calabrese, and D.A. Butterfield, "Elevation of Mitochondrial Glutathione by ( y-Glutamylcysteine Ethyl Ester Protects Mitochondria Against Peroxynitrite-Induced Oxidative Stress," (2003).

273. D.A. Butterfield, and A. Castegna, "Proteomics for the Identification of Specifically Oxidized Proteins in Brain: Technology and Application to the Study of Neurodegenerative Disorders," (2003).

272. V. Calabrese, G. Scapagnini, A. Ravagna, R. Bella, A.M. Giuffrida Stella, M. Calvani, D.A. Butterfield, and G. Pennisi, "Disruption of Thiol Homeostasis and Nitrosative Stress in the Cerebrospinal Fluid of Patients with Active Multiple Sclerosis: Evidence for a Protective Role of Acetylcarnitine," (2003).

271. A.B. Downie, D. Zhang, L.M.A. Dirk, R.R. Thacker, J.A. Pfeiffer, J.L. Drake, A.A. Levy, D.A. Butterfield, J. W. Buxton, and J. C. Snyder, "Communication Between the Maternal Testa and the Embryo and/or Endosperm Affect Testa Attributes in Tomato," (2003).

270. D.A. Butterfield and A. Castegna, "Proteomic Analysis of Oxidatively Modified Proteins in Alzheimer's Disease Brain: Insights into Neurodegeneration," Cellular and Molecular Biology 49, 747-751 (2003).

269. J. Kanski, R. Sultana, W. Klunk, and D.A. Butterfield, "Antioxidant Activity of X-34 in Synaptosomal and Neuronal Systems," (2003).

268. D.A. Butterfield and A. Castegna, "Energy Metabolism in Alzheimer's Disease Brain: Insights From Proteomics," Applied Genomics and Proteomics, 2, 67-70 (2003).

267. D.A. Butterfield, D. Boyd-Kimball, and A. Castegna, "Proteomics in Alzheimer's Disease: Insights into Mechanisms of Neurodegeneration," (2003).

266. D.A. Butterfield, "Amyloid β-Peptide [1-42]-Associated Free Radical-Induced Oxidative Stress and Neurodegeneration in Alzheimer's Disease Brain: Mechanisms and Consequences," (2003).

265. D.A. Butterfield and D. Bhattacharyya, "Biofunctional Membranes: Site-Specifically Immobilized Enzyme Arrays," in: New Insights Into Membrane Science and Technology: Polymeric and Biofunctional Membranes, D. Bhattacharyya and D. A. Butterfield, Eds., .

264. D. Bhattacharyya and D.A. Butterfield, "New Insights Into Membrane Science and Technology: Polymeric and Biofunctional Membranes," .

263. Q. Ding, K. Reinacker, E. Dimayuga, V. Nukala, J. Drake, D.A. Butterfield, J. C. Dunn, S. Martin, A.J. Bruce-Keller, and J.N. Keller, "Role of the Proteasome in Protein Oxidation and Neural Viability Following Low-Level Oxidative Stress," (2003).

262. D.A. Butterfield and C.B. Pocernich, "The Glutamatergic System and Alzheimer's Disease: Therapeutic Implications," (2003).

261. A. Castegna, V. Thongboonkerd, J.B. Klein, B. Lynn, W.R. Markesbery, and D.A. Butterfield, "Proteomic Identification of Nitrated Proteins in Alzheimer's Disease Brain," (2003).

260. C.B. Pocernich and D.A. Butterfield, "Acrolein Inhibits NADH-Linked Mitochondrial Enzyme Activity: Implications for Alzheimer's Disease," Neurotoxicity Research 5, 515-520 (2003).

259. A. Chauhan, J. Turchan, C. Pocernich, A. Bruce-Keller, S. Roth, D.A. Butterfield, E.O. Major, and A. Nath, "Intracellular Human Immunodeficiency Virus Tat Expression in Astrocytes Promotes Astrocyte Survival But Induces Potent Neurotoxicity at Distant Sites via Axonal Transport," (2003).

258. S.A. Farr, H.F. Poon, D. Dogrukol-Ak, J. Drake, W.A. Banks, E. Eyerman, D.A. Butterfield, and J.E. Moreley, "The Antioxidants" a-Lipoic Acid and N-Acetylcysteine Reverse Memory Impairment and Brain Oxidative Stress in Aged SAMP8 Mice,"Journal of Neurochemistry 84, 1173-1183 (2003).

257. J. Drake, C.D. Link, and D.A. Butterfield, "Oxidative Stress Precedes Fibrillar Deposition of Alzheimer's Disease Amyloid β-Peptide (1-42) in a Transgenic Caenorhabditis Elegans Model," (2003).

256. C.M. Lauderback, J. Drake, D. Zhou, J.M. Hackett, A. Castegna, J. Kanski, M. Tsoras, S. Varadarajan, and D.A. Butterfield, "Derivatives of Xanthic Acid are Novel Antioxidants: Application to Synaptosomes," Free Radical Res. 37, 355-365 (2003).

255. J. Turchan, C.B. Pocernich, C. Gairola, A. Chauhan, G. Schifitto, D.A. Butterfield, S. Buch, O. Narayan, A. Sinai, J. Geiger, J.R. Berger, H. Elford, and A. Nath, "Oxidative Stress in HIV Demented Patients and Protection Ex-Vivo with Novel Antioxidants," Neurology 60, 307-314 (2003).

254. D.A. Butterfield, "Alzheimer's Disease: Free Radicals Run Amok," Drug Discovery & Development 6, 12 (2003).

253. A. Castegna, J. Drake, C. Pocernich, and D.A. Butterfield, "Protein Carbonyl Levels, an Assessment of Protein Oxidation," Apoptosis Methods in Pharmacology and Toxicology: Methods in Biological and Oxidative Stress, K. Hensley and R. A. Floyd, Eds., Human Press, Totowa, NJ, 2003, pp. 161-168.

252. D.A. Butterfield, "Electron Paramagnetic Resonance Spin Labeling Analysis of Synaptosomal Membrane Protein Oxidation," Apoptosis Methods in Pharmacology and Toxicology: Methods in Biological and Oxidative Stress, K. Hensley and R. A. Floyd, Eds., Human Press, Totowa, NJ, 2003, pp. 79-86.

251. V. Calabrese, G. Scapagnini, S. Latteri, C. Colombrita, A. Ravagna, C. Catalano, G. Pennisi, M. Calvani, and D.A. Butterfield, "Long-Term Ethanol Administration Enhances Age-Dependent Modulation of Redox State in Different Brain Regions in the Rat: Protection by Acetyl Carnitine," Int. J. Tissue React. 24, 97-104 (2002).

250. V. Calabrese, G. Scapagnini, S. Jong, D.A. Butterfield, and U. Scapagnini, "Heme Oxygenase, Carbon Monoxide and Cellular Stress Response in the Nervous System: The Good and the Enigmatic," Neurochemistry News 2, 57-60 (2002).

249. D.A. Butterfield, "Amyloid β-Peptide (1-42)-Induced Oxidative Stress and Neurotoxicity: Implications for Neurodegeneration in Alzheimer's Disease Brain. A Review," (2002).

248. D.A. Butterfield, C. B. Pocernich and J. Drake, "Elevated Gutathione as a Therapeutic Strategy in Alzheimer's Disease," (2002).

247. D.A. Butterfield, J. Colvin, J. Liu, J. Wang, L. Bachas, and D. Bhattacharyya, "Electron Paramagnetic Resonance Spin Label Titration: A Novel Method to Investigate Random and Site-Specific Immobilization of Enzymes onto Polymeric Membranes with Different Properties," Analytica Chimica Acta 470, 29-36 (2002).

246. D.A. Butterfield, A. Castegna, C.M. Lauderback, and J. Drake,"Review: Evidence that Amyloid Beta-Peptide-Induced Lipid Peroxidation and Its Sequelae in Alzheimer's Disease Brain Contributes to Neuronal Death," (2002).

245. D.A. Butterfield, S. Griffin, G. Munch, and G.M. Pasinetti, "Amyloid β-Peptide and Amyloid Pathology are Central to the Oxidative Stress and Inflammatory Cascades Under Which Alzheimer's Disease Brain Exists," (2002).

244. A. Castegna, M. Aksenov, M. Aksenova, V. Thongboonkerd, J.B. Klein, W.M. Pierce, R. Booze, W.R. Markesbery, and D.A. Butterfield, "Proteomic Identification of Oxidatively Modified Proteins in Alzheimer's Disease Brain. Part II: Dihydropyrimidinase-Related Protein 2, " a-Enolase, and Heat Shock Cognate 71," (2002).

243. D.A. Butterfield, A. Castegna, C.B. Pocernich, J. Drake, G. Scapagnini, and V. Calabrese, "Nutritional Approaches to Combat Oxidative Stress in Alzheimer's Disease," J. Nutritional Biochemistry 13, 444-461 (2002).

242. D.A. Butterfield and J. Kanski, "Review: Methionine Residue 35 is Critical for the Oxidative Stress and Neurotoxic Properties of Alzheimer's Amyloid β-Peptide 1-42," (2002).

241. A. Castegna, M. Aksenov, M. Aksenova, V. Thongboonkerd, J.B. Klein, W.M. Pierce, R. Booze, W.R. Markesbery, and D.A. Butterfield, "Proteomic Identification of Oxidatively Modified Proteins in Alzheimer's Disease Brain. Part I: Creatine Kinase BB, Glutamine Synthase, and Ubiquitin Carboxy-Terminal Hydrolase L-1," (2002).

240. V. Calabrese, G. Scapagnini, A. Ravagna, A.M. Giuffrida Stella, and D.A. Butterfield, "Molecular Chaperones and Their Roles in Neural Cell Differentiation," (2002).

239. D.A. Butterfield, A. Castegna, J. Drake, G. Scapagnini, and V. Calabrese, "Vitamin E and Neurodegenerative Disorders Associated with Oxidative Stress," (2002).

238. J. Drake, J. Kanski, S. Varadarajan, M. Tsoras, and D.A. Butterfield, "Elevation of Brain Glutathione by ( y-Glutamylcysteine Ethyl Ester Protects Against Peroxynitrite-Induced Oxidative Stress," (2002).

237. M.A. LaFontaine, J.W. Geddes, and D.A. Butterfield, "3-Nitropropionic Acid-Induced Changes in Bilayer Fluidity in Synaptosomal Membranes: Implications for Huntington's Disease," Brain Research 27, 507-511 (2002).

236. J. Kanski, M. Aksenova, and D.A. Butterfield, "The Hydrophobic Environment of Met35 of Alzheimer's Aβ(1-42) is Important for the Neurotoxic and Oxidative Properties of the Peptide," (2002).

235. J. Kanski, M. Aksenova, A. Stoyanova, and D.A. Butterfield, "Ferulic Acid Antioxidant Protection Against Hydroxyl and Peroxyl Radical Oxidation in Synaptosomal and Neuronal Cell Culture Systems In Vitro : Structure-Activity Studies," (2002).

234. J. Kanski, M. Aksenova, C. Schoneich, and D.A. Butterfield, "Substitution of Isoleucine-31 by Helical-Breaking Proline Abolishes Oxidative Stress and Neurotoxic Properties of Alzheimer's Amyloid β-Peptide (1-42)," (2002).

233. D.A. Butterfield and C.M. Lauderback, "Lipid Peroxidation and Protein Oxidation in Alzheimer's Disease Brain: Potential Causes and Consequences Involving Amyloid β-Peptide-Associated Free Radical Oxidative Stress," (2002).

232. M. Aksenova, D.A. Butterfield, S. Zhang, M. Underwood, and J.W. Geddes, "Increased Protein Oxidation and Decreased Creatine Kinase BB Expression and Activity Following Spinal Cord Contusion Injury,"J. Neurotrauma 19, 491-502 (2002).

231. J. Kanski, S. Varadarajan, M. Aksenova, and D.A. Butterfield, "Role of Glycine-33 and Methionine-35 in Alzheimer's Amyloid β-Peptide 1-42-Associated Oxidative Stress and Neurotoxicity," (2002).

230. M.A. LaFontaine, M.P. Mattson, and D.A. Butterfield, "Oxidative Stress in Synaptosomal Proteins From Mutant Presenilin-1 Knock-In Mice: Implications for Familial Alzheimer's Disease," (2002).

229. C.M. Lauderback, J. Kanski, J.M. Hackett, N. Maeda, M. S. Kindy, and D.A. Butterfield, "Apolipoprotein E Modulates Alzheimer's Aβ(1-42)-Induced Oxidative Damage to Synaptosomes in an Allele-Specific Manner," (2002).

228. D.A. Butterfield, J. Drake, C. Pocernich, and A. Castegna, "Evidence of Oxidative Damage in Alzheimer's Disease Brain: Central Role of Amyloid β-Peptide," Trends Molecular Med. 7, 548-554 (2001).

227. J. Kanski, J. Drake, M. Aksenova, L. Engman, and D.A. Butterfield, "Antioxidant Activity of the Organotellurium Compound 3-[4-( N , N -Dimethylamino)benzenetellurenyl]-propanesulfonic Acid Against Oxidative Stress in Synaptosomal Membrane Systems and Neuronal Cultures," (2001).

226. C.B. Pocernich, A.L. Cardin, C.L. Racine, C.M. Lauderback, and D.A. Butterfield, "Glutathione Elevation and Its Protective Role in Acrolein-Induced Protein Damage in Synaptosomal Membranes: Relevance to Brain Lipid Peroxidation in Neurodegenerative Disease," (2001).

225. D. Zhou, C.M. Lauderback, T. Yu, S.A. Brown,D.A. Butterfield, and J. S. Thompson, "D609 Inhibits Ionizing Radiation-Induced Oxidative Damage by Acting as a Potent Antioxidant," (2001).<

224. C.M. Lauderback, J.M. Hackett, F.F. Huang, J.N. Keller, L.I. Szweda, W.R. Markesbery, and D.A. Butterfield, "The Glial Glutamate Transporter, GLT-1, is Oxidatively Modified by 4-Hydroxy-2-Nonenal in the Alzheimer's Disease Brain: Role of Ab 1-42," (2001).

223. S. Varadarajan, J. Kanski, M. Aksenova, C. Lauderback, and D.A. Butterfield, "Different Mechanisms of Oxidative Stress and Neurotoxicity for Alzheimer's Aβ(1-42) and Ab(25-35)," (2001).

222. D.A. Butterfield, B.J. Howard, and M.A. La Fontaine, "Brain Oxidative Stress in Animal Models of Accelerated Aging and the Age-Related Neurodegenerative Disorders, Alzheimer's Disease and Huntington's Disease," (2001).

221. D.A. Butterfield and J. Kanski, "Brain Protein Oxidation in Age-Related Neurodegenerative Disorders that are Associated with Aggregated Proteins," (2001).

220. M.Y. Aksenov, M.V. Aksenova, D.A. Butterfield, J.W. Geddes, and W.R. Markesbery, "Protein Oxidation in the Alzheimer's Disease Brain: Analysis of Protein Carbonyls by Immunocytochemistry and Two-Dimensional Western Blotting," (2001).

219. C.M. Lauderback, J.M. Hackett, J.N. Keller, S. Varadarajan, L. Sweda, M. Kindy, W.R. Markesbery, and D.A. Butterfield, "Vulnerability of Synaptosomes From Apoe Knock-Out Mice to Structural and Oxidative Modifications Induced by Aβ(1-40): Implications for Alzheimer's Disease," (2001).

218. S.M. Yatin, M. Yatin, S. Varadarajan, K.B. Ain, and D.A. Butterfield, "Role of Spermine and Amyloid β-Peptide (1-42) Associated Free Radical Induced Neurotoxicity," (2001).

217. J. Kanski, C. Lauderback, and D.A. Butterfield, "5-Aminosalicylic Acid Protection Against Oxidative Damage to Synaptosomal Membranes by Alkoxyl Radicals in vitro," (2001).

216. D.A. Butterfield, D. Bhattacharyya, S. Daunert, and L.G. Bachas, "Catalytic Biofunctional Membranes Containing Site-Specifically Immobilized Enzyme Arrays," (2001).

215. G.T. Wondrak, S. Varadarajan, D.A. Butterfield, and M.K. Jacobson, "Formation of a Protein-Bound Pyrazinium Free Radical Cation During Glycation of Histone H1," (2000).

214. M.A. La Fontaine, J.W. Geddes, A. Banks, and D.A. Butterfield, "Effect of Exogenous and Endogenous Antioxidants on 3-Nitropropionic Acid-Induced In-Vivo Oxidative Stress and Striatal Lesions: Insights into Huntington's Disease," (2000).

213. W.F. Maragos, R. Jakel, D. Chesnut, C.B. Pocernich, D.A. Butterfield, D. St. Clair, and W.A. Cass, "Methamphetamine Toxicity is Attenuated in Mice that Overexpress Human Manganese Superoxide Dismutase," (2000).

212. G. Liu, Y.L. Xiong, and D.A. Butterfield, "Chemical, Physical, and Gel-Forming Properties of Oxidized Myofibrillar, Whey, and Soy Protein Isolates," (2000).

211. S. Varadarajan, S. Yatin, M. Aksenova, and D.A. Butterfield, "Review: Alzheimer's Amyloid β-Peptide-Associated Free Radical Oxidative Stress and Neurotoxicity," J. Struct. Biol. 130, 184-208 (2000).

210. S.M. Yatin, S. Varadarajan, and D.A. Butterfield, "Vitamin E Prevents Alzheimer's Amyloid β-Peptide (1-42)-Induced Protein Oxidation and Reactive Oxygen Species Formation," (2000).

209. C.M. Lauderback, A.M. Breier, J. Hackett, S. Varadarajan, J. Goodlett-Mercer, and D.A. Butterfield, "The Pyrrolopyrimidine U101033E is a Potent Free Radical Scavenger and Prevents Fe(II)-Induced Lipid Peroxidation in Synaptosomal Membranes," (2000).

208. Z.-H. Guo, A. Ersoz, D.A. Butterfield, and M. P. Mattson, "Beneficial Effects of Dietary Restriction on Cerebral Cortical Synaptic Terminals: Preservation of Glucose Transport and Mitochondrial Function Following Oxidative and Metabolic Insults," (2000).

207. M. Aksenov, M. Aksenova, D.A. Butterfield, and W.R. Markesbery, "Oxidative Modification of Creatine Kinase BB in Alzheimer's Disease Brain," (2000).

206. J.N. Keller, C.M. Lauderback, D.A. Butterfield, M.S. Kindy, and W.R. Markesbery, "Amyloid β-Peptide Effects on Synaptosomes From Apolipoprotein E-Deficient Mice," (2000).

205. S. Varadarajan, S. Yatin, and D.A. Butterfield, "Alzheimer's Amyloid β-Peptide (1-42) Fibrils Are Not Always Toxic," Alzheimer's Reports 3, 71-76 (2000).

204. D.A. Butterfield, "Alzheimer’s Amyloid β-Peptide-Associated Oxidative Stress: Brain Membrane Lipid Peroxidation and Protein Oxidation," in Membrane Structure in Disease and Drug Therapy, G. Zimmer, Ed., Marcel Dekker, New York, 2000, pp. 335-352.

203. M.A. La Fontaine, J.W. Geddes, A. Banks, and D.A. Butterfield, "3-Nitropropionic Acid Induced In-Vivo Protein Oxidation in Striatal and Cortical Synaptosomes: Insights into Huntington's Disease," Brain Research 858, 356-362 (2000).

202. C.B. Pocernich, M. La Fontaine, and D.A. Butterfield, " In-Vivo Glutathione Elevation Protects Against Hydroxyl Free Radical-Induced Protein Oxidation in Rat Brain," (2000).

201. D.A. Butterfield, S.M. Yatin, and C.D. Link, " In-Vitro and In-Vivo Protein Oxidation Induced by Alzheimer's Disease Amyloid β-Peptide (1-42)," Ann.N.Y. Acad. Sci. 893, 265-268 (1999).

200. D.A. Butterfield, S. Varadarajan, M. Aksenova, C. Link, and S.M. Yatin, "On Methionine and Alzheimer's Amyloid β-Peptide (1-42)-Induced Oxidative Stress," Neurobiology of Aging 20, 339-342 (1999).

199. S.M. Yatin, C.D. Link, and D.A. Butterfield, " In-Vitro and In-Vivo Oxidative Stress Associated with Alzheimer’s Amyloid β-Peptide (1-42)," (1999).

198. S.P. Gabbita, J.M. Carney, and D.A. Butterfield, "Effects of Brain Mitochondrial Metabolism, Aging, and Caloric Restriction on Membrane Lipids and Proteins," in .

197. S. Varadarajan, S. Yatin, J. Kanski, F. Jahanshaki, and D.A. Butterfield, "Methionine Residue 35 Is Important In Amyloid β-Peptide-Associated Free Radical Oxidative Stress," (1999).

196. M. Aksenova, M.Y. Aksenov, W.R. Markesbery, and D.A. Butterfield, "Aging in a Dish: Age-Dependent Changes of Neuronal Surrival, Protein Oxidation, and Creatine Kinase BB Expression in Long-Term Hippocampal Cell Culture," (1999).

195. D.A. Butterfield, "Amyloid β-Peptide-Associated Free Radical Oxidative Stress and Alzheimer's Disease," in .

194. D.A. Butterfield, S.M. Yatin, S. Varadarajan, and T. Koppal, "Amyloid β-Peptide-Induced Oxidative Pathways of Cell Death," Methods Enzymology 309, 746-768 (1999).

193. C.M. Lauderback, M.E. Harris-White, Y. Wang, N.W. Pedigo, Jr., J.M. Carney, and D.A. Butterfield, "Amyloid β-Peptide Inhibits Na +-Dependent Glutamate Uptake," Life Sciences 65, 1977-1981 (1999).

192. D.A. Butterfield, B. Howard, S. Yatin, T. Koppal, J. Drake, K. Hensley, M. Aksenov, M. Aksenova, R. Subramaniam, S. Varadarajan, M.E. Harris-White, N.W. Pedigo, Jr., and J.M. Carney, "Elevated Oxidative Stress in Models of Normal Brain Aging and Alzheimer’s Disease," Life Sciences 65, 1883-1892 (1999).

191. S.M. DeAtley, M.Y. Aksenov, M.V. Aksenova, B. Jordan, J.M. Carney, and D.A. Butterfield, "Adriamycin-Induced Changes of Creatine Kinase Activity In Vivo and in Cardiomyocyte Culture," (1999).

190. D.A. Butterfield, T. Koppal, R. Subramaniam, and S. Yatin," Vitamin E as an Antioxidant/Free Radical Scavenger Against Amyloid β-Peptide-Induced Oxidative Stress in Neocortical Synaptosomal Membranes and Hippocampal Neurons in Culture: Insights into Alzheimer's Disease," (1999).

189. J. Kanski, T. Koppal, and D.A. Butterfield, "Investigation of Peroxynitrite Induced Oxidative Stress in Red Blood Cells Monitored by Luminol-Dependent Chemiluminescence," Analyt. Letts. 32, 1183-1192 (1999).

188. S.M. Yatin, M. Aksenova, M. Aksenov, and D.A. Butterfield, "Effect of Transglutaminase on Ab 1-40 Fibril Formation and Neurotoxicity," Alzheimer's Reports 2, 165-170 (1999).

187. T. Koppal, J. Drake, and D.A. Butterfield, " In-Vivo Modulation of Rodent Glutathione and Its Role In Peroxynitrite-Induced Neocortical Synaptosomal Membrane Protein Damage," Biochimica et Biophysica Acta 1453, 407-411 (1999).

186. M.Y. Aksenov, H.M. Tucker, P. Nair, S. Estus, M.V. Aksenova, D.A. Butterfield, and W.R. Markesbery, "The Expression of Several Mitochondrial and Nuclear Genes Encoding the Subunits of Electron Transport Chain Enzyme Complexes, Cytochrome c Oxidase and NADH Dehydrogenase, in Different Brain Regions in Alzheimer’s Disease," (1999).

185. S.M. Yatin, M. Yatin, T. Aulick, K.B. Ain, and D.A. Butterfield, "Alzheimer’s Amyloid β-Peptide Generated Free Radicals Increase Rat Embryonic Neuronal Polyamine Uptake and ODC Activity: Protective Effect of Vitamin E," Neuroscience Letts. 263, 17-20 (1999).

184. D.A. Butterfield, "Alzheimer's Amyloid β-Peptide and Free Radical Oxidative Stress," in: Reactive Oxygen Species in Biological Systems: An Interdisciplinary Approach, (D. L. Gilbert and C. A. Colton, Eds.), Plenum Press, New York, 1999, pp. 609-638.

183. M.V. Aksenova, M.Y. Aksenov, R.M. Payne, J.Q. Trojanowski, J.M. Carney, D.A. Butterfield, and W.R. Markesbery, "Oxidation of Cytosolic Proteins and Expression of Creatine Kinase BB in Frontal Cortex in Different Neurodegenerative Disorders," Dementia and Geriatric Cognitive Disorders 10, 158-165 (1999).

182. S.M. DeAtley, M.Y. Aksenov, M.V. Aksenova, B. Harris, R. Hadley, P.C. Harper, J.M. Carney, and D.A. Butterfield, "Antioxidants Protect Against Reactive Oxygen Species Associated with Adriamycin-Treated Cardiomyocytes," (1999).

181. S.M. Yatin, M. Aksenov, and D.A. Butterfield, "The Antioxidant Vitamin E Modulates Amyloid β-Peptide-Induced Creatine Kinase Activity Inhibition and Increased Protein Oxidation: Implications for the Free Radical Hypothesis of Alzheimer’s Disease," (1999).

180. T. Koppal, J. Drake, S. Yatin, B. Jordan, S. Varadarajan, L. Bettenhausen, and D.A. Butterfield, "Peroxynitrite-Induced Alterations in Synaptosomal Membrane Proteins: Insight Into Oxidative Stress in Alzheimer’s Disease," (1999).

179. S.M. Yatin, M. Aksenova, M. Aksenov, W.R. Markesbery, T. Aulick, and D.A. Butterfield, "Temporal Relations Between Amyloid β-Peptide-Induced Free Radical Oxidative Stress and Neuronal Toxicity and Neuronal Defensive Responses," (1999).

178. M.Y. Aksenov, H.M. Tucker, P. Nair, M.V. Aksenova, D.A. Butterfield, S. Estus, and W.R. Markesbery, "The Expression of Key Oxidative Stress Handling Genes in Different Brain Regions in Alzheimer’s Disease," 1998).

177. S. Ganapathi-Desai, D.A. Butterfield, and D. Bhattacharyya, "Kinetics and Active Fraction Determination of a Protease Enzyme Immobilized on Functionalized Membranes: Mathematical Modeling and Experimental Results," Biotechnology Prog. 14, 865-873 (1998).

176. D.A. Butterfield, T. Koppal, B. Howard, R. Subramaniam, N. Hall, K. Hensley, S. Yatin, K. Allen, M. Aksenov, M. Aksenova, and J. Carney, "Structural and Functional Changes in Proteins Induced by Free Radical-Mediated Oxidative Stress and Protective Action of the Antioxidants N-tert-butyl-a-phenylnitrone (PBN) and Vitamin E," Ann. N. Y. Acad. Sci. 854, 448-462 (1998).

175. S. Vishwanath, J. Wang, L.G. Bachas, D.A. Butterfield, and D. Bhattacharyya, "Site-Directed and Random Immobilization of Subtilisin on Functionalized Membranes: Activity Determination in Aqueous and Organic Media," Biotech. & Bioeng. 60, 608-616 (1998).

174. R. Subramaniam, T. Koppal, M. Green, S. Yatin, B. Jordan, and D.A. Butterfield, "The Free Radical Antioxidant Vitamin E Protects Cortical Synaptosomal Membrane Proteins From Amyloid β-Peptide (25-35) Toxicity But Not From Hydroxynonenal Toxicity: Relevance to the Free Radical Hypothesis of Alzheimer's Disease," (1998).

173. J.G. Begley, D.A. Butterfield, J.N. Keller, T. Koppal, J. Drake, and M.P. Mattson, "Cryopreservation of rat cortical synaptosomes and analysis of glucose and glutamate transporter activities, and itochondrial function," Brain Res., Brain Res. Protocols 3, 76-82 (1998).

172. M.Y. Aksenov, M.V. Aksenova, W.R. Markesbery, and D.A. Butterfield, "Amyloid β-Peptide(1-40) - Mediated Oxidative Stress in Cultured Hippocampal Neurons: Protein Carbonyl Formation, CK BB Expression and the Level of Cu, Zn and Mn SOD mRNA," (1998).

171. S.M. DeAtley, M.Y. Aksenov, M.V. Aksenova, J.M. Carney, and D.A. Butterfield, "Adriamycin Induces Protein Oxidation in Erythrocyte Membranes," Pharmacol. Toxicol. 83, 62-68 (1998).

170. S.P. Gabbita, R. Subramaniam, F. Allouch, J.M. Carney, and D.A. Butterfield, "Effects of Mitochondrial Respiratory Stimulation on Membrane Lipids and Proteins: An Electron Paramagnetic Resonance Investigation," (1998).

169. T. Koppal, R. Subramaniam, J. Drake, M.R. Prasad, and D.A. Butterfield, "Vitamin E Protects Against Amyloid Peptide (25-35)-Induced Changes in Neocortical Synaptosomal Membrane Lipid Structure and Composition," Brain Res. 786, 270-273 (1998).

168. M.N. Aksenova, M.Y. Aksenov, J.M. Carney, and D.A. Butterfield, "Protein Oxidation and Enzyme Activity Decline in Old Brown Norway Rats Are Reduced by Dietary Restriction," (1998).

167. A.J. Bruce-Keller, J.G. Begley, W. Fu, D.A. Butterfield, D.E. Bredesen, J.B. Hutchins, K. Hensley, and M.P. Mattson, "Bcl-2 Protects Isolated Plasma and Mitochondrial Membranes Against Lipid Peroxidation Induced by Hydrogen Peroxide and Amyloid β-Peptide," (1998).

166. M.Y. Aksenov, M.V. Aksenova, J.M. Carney, and D.A. Butterfield, "Oxidative Modification of Glutamine Synthetase by Amyloid Beta Peptide," Free Radical Res. 27, 267-281 (1997).

165. R. Subramaniam, F. Roediger, B. Jordan, M.P. Mattson, J.N. Keller, G. Waeg, and D.A. Butterfield, "The Lipid Peroxidation Product, 4-Hydroxy-2-Trans-Nonenal, Alters the Conformation of Cortial Synaptosomal Membrane Proteins," (1997).

164. S.P. Gabbita, D.A. Butterfield, and J. Carney, "Neurodegeneration and Potential Antioxidant Based Therapeutic Aproaches," in Mitochondria and Free Radicals in Neurodegenerative Diseases, (M. F. Beal, N. Howell and I. Bodis-Wollner, Eds.), 1997, pp. 497-512.

163. D.A. Butterfield and E.R. Stadtman, "Protein Oxidation Processes in Aging Brain," (1997).

162. S.P. Gabbita, K. Hensley, D.A. Butterfield, and J.M. Carney, "Aging and Caloric Restriction Affect Mitochondrial Respiration and Lipid Membrane Status: An Electron Paramagnetic Resonance Investigation," (1997).

161. D.A. Butterfield, K. Hensley, P. Cole, R. Subramaniam, M. Aksenov, M. Aksenova, P.M. Bummer, B.E. Haley, and J.M. Carney, "Oxidatively-Induced Structural Alteration of Glutamine Synthetase Assessed by Analysis of Spin Labeled Incorporation Kinetics: Relevance to Alzheimer's Disease," (1997).

160. D.A. Butterfield, R. Subramaniam, P.S. Cole, S. Yatin, K. Hensley, N.C. Hall, and J.M. Carney, "Electron Paramagnetic Resonance Studies of Amyloid β-Peptide- and Ischemia/-Reperfusion-Associated Oxygen Free Radicals and the Membrane Damage They Cause: Relevance to Alzheimer's Disease and Stroke," in .

159. D.A. Butterfield, "β-Amyloid-Associated Free Radical Oxidative Stress and Neurotoxicity: Implications for Alzheimer's Disease," (1997).

158. D.A. Butterfield, R. Subramaniam, D. Bhattacharyya, S. Viswanath, W. Huang, and L. Bachas, "Biofunctional Membranes: Electron Paramagnetic Resonance Studies of the Active Site Structure of Enzymes Site-Specifically Immobilized onto Polymeric Supports Through Molecular Recognition," Polymeric Materials Science and Engineering Preprints 76, 602-603 (1997).

157. N.C. Hall, J.M. Carney, O.J. Plante, M. Cheng, and D.A. Butterfield, "Effect of 2-Cyclohexene-1-one-Induced Glutathione Diminution on Ischemia/Reperfusion-Induced Alterations in the Physical State of Brain Synaptosomal Membrane Proteins and Lipids," (1997).

156. D.A. Butterfield, B.J. Howard, S. Yatin, K.L. Allen, and J.M. Carney, "Free Radical Oxidation of Brain Proteins in Accelerated Senescence and Its Modulation by N-Tert-Butyl-a-Phenylnitrone," Proc. Nat. Acad. Sci. USA 94, 674-678 (1997).

155. P.S. Cole, M.E. Harris, J.M. Carney, N.C. Hall, and D.A. Butterfield, "Methods of Evaluating Protein Oxidation Induced by Ischemia/Reperfusion Injury," in (1997).

154. P.S. Cole, N.C. Hall, J.M Carney, O.J. Plante, and D.A. Butterfield, "Free Radical Oxidative Stress and Membrane Alterations in Ischemia/Reperfusion Injury," Recent Res. Develop. in Neurochem. 1, 99-109 (1996).

153. M. Aksenov, M. Aksenova, J.M. Carney, and D.A. Butterfield, "Alpha 1-Antichymotrypsin Interaction with Aβ(1-42) Does Not Inhibit Fibril Formation But Altenuates the Peptide Toxicity," Neuroscience Letts. 217, 117-120 (1996).

152. D.A. Butterfield, K. Hensley, N. Hall, R. Subramaniam, B.J. Howard, P. Cole, S. Yatin, M. La Fontaine, M.E. Harris, M. Aksenova, M. Aksenov, and J.M. Carney, "β-Amyloid-Derived Free Radical Oxidation: A Fundamental Process in Alzheimer's Disease," in .

151. B.J. Howard, S. Yatin, K. Hensley, K.L. Allen, J.P. Kelly, J. Carney, and D.A. Butterfield, "Prevention of Hyperoxia-Induced Alterations in Synaptosomal Membrane-Associated Proteins by N-Tert-Butyl- " -Phenylnitrone (PBN) and 4-Hydroxy-2,2,6,6-Tetramethylpiperidine-1-Oxyl (Tempol)," J. Neurochem. 67, 2045-2050 (1996).

150. W.J. Clerici, K. Hensley, D.L. DiMartino, and D.A. Butterfield, "Direct Detection of Ototoxicant-Induced Reactive Oxygen Species Generation in Cochlear Explants," Hearing Res. 98, 116-124 (1996).

149. A. Bhardwaj, J. Lee, K. Glauner, S. Ganapathi, D. Bhattacharyya, and D.A. Butterfield, "Biofunctional Membranes: An EPR Study of Active Site Structure and Stability of Papain Non-Covalently Immobilized on the Surface of Modified Poly (Ether) Sulfone Membranes Through the Avidin-Biotin Linkage," J. Membrane Sci. 119, 241-252 (1996).

148. D.A. Butterfield, "Alzheimer's Disease: A Disorder of Oxidative Stress," Alzheimer's Disease Rev. 1, 68-70 (1996).

147. M.E. Harris, Y. Wang, N.W. Pedigo, Jr., K. Hensley, D.A. Butterfield, and J.M. Carney, "Aβ(25-35) Inhibits Na +-Dependent Glutamate Uptake in Rat Hippocampal Astrocyte Cultures," J. Neurochemistry 67, 277-286 (1996).

146. J.M. Carney, N.C. Hall, M. Cheng, J. Wu, and D.A. Butterfield, "Protein and Lipid Oxidation Following Ischemia/Reperfusion Injury, the Role of Polyamines: An Electron Paramagnetic Resonance Analysis," Adv. Neurol. 71, 259-270 (1996).

145. R. Subramaniam, P. Cole, K. Hensley, S. Azhar, P. Bummer, J.M. Carney, and D.A. Butterfield, "Effects of Oxidative Stress on the Model Thiol Protease-Papain: An Investigation of Changes in Activity and Structure," Biochemical Arch. 12, 105-116 (1996).

144. M.V. Aksenova, M.Y. Aksenov, D.A. Butterfield, and J.M. Carney, "Alpha 1-Antichymotrypsin Interaction with Aβ(1-40) Inhibits Fibril Formation But Does Not Affect the Peptide Toxicity," Neuroscience Letts. 211, 45-48 (1996).

143. K. Hensley, D.A. Butterfield, N. Hall, P. Cole, R. Subramaniam, R. Mark, M.P. Mattson, W.R. Markesbery, M.E. Harris, M. Aksenov, M. Aksenova, J.F. Wu, and J.M. Carney, "Reactive Oxygen Species as Causal Agents in the Neurotoxicity of the Alzheimer's Disease-Associated Amyloid Beta Peptide," Ann. N.Y. Acad. Sci. 786, 120-134 (1996).

142. M.Y. Aksenov, M.V. Aksenova, D.A. Butterfield, K. Hensley, C. Vigo-Pelfrey, and J.M. Carney, "Glutamine Synthetase-Induced Enhancement of β-Amyloid Peptide Aβ(1–40) Neurotoxicity Accompanied by Abrogation of Fibril Formation and Aβ Fragmentation," J. Neurochem. 66, 2050-2056 (1996).

141. R. Subramaniam and D.A. Butterfield, "Structure-Activity Correlation of Subtilisin Immobilized on Modified Poly (Ether) Sulfone Membrane by Covalent and Non-Covalent Linkages," in .

140. A. Bhardwaj, J. Lee, K. Glauner, D. Bhattacharyya, and D.A. Butterfield, "Non-Covalent Immobilization of Papain Onto Modified Polysulfone Membrane Using Avidin-Biotin Coupling: EPR and Kinetic Studies," in .

139. J. Lee, D. Bhattacharyya, and D.A. Butterfield, "A Comparative Study of the Structural and Kinetic Properties of Papain Immobilized on Modified Polysulfone and Modified Cellulose Acetate Membranes," in .

138. D. Bhattacharyya, S. Ganapathi, S. Vishwanath, M. Summers, and D.A. Butterfield, "Immobilized Enzyme Reactions On Beads and Membranes," in .

137. D.A. Butterfield, "Biofunctional Membranes," Plenum Press, New York, (1996).

136. A.A. Houdi, S. Kottayil, P.A. Crooks, and D.A. Butterfield, "3-O-Acetylmorphine-6-O-Sulfate: A Potent Centrally-Acting Morphine Derivative," Pharmacol. Biochem. Behav. 53, 665-671 (1996).

135. C.P. Brock, S. Kottayil, D.A. Butterfield, and P.A. Crooks, "A Dihydromorphine-6-O-sulfate," (1996).

134. E.A. Decker, W.K. M. Chan, S.A. Livisay, D.A. Butterfield, and C. Faustman, "Interactions Between Carnosine and the Different Redox States of Myoglobin," J. Food Sci. 60, 1201-1204 (1996).

133. D.A. Butterfield, L. Martin, J.M. Carney, and K. Hensley, "Aβ (25-35) Peptide Displays H 2O 2-Like Reactivity Towards Aqueous Fe 2+, Nitroxide Spin Probes, and Synaptosomal Membrane Proteins," (1996).

132. D.A. Butterfield, "Membrane Cytoskeletal Protein Alterations in Alzheimer's Disease," in .

131. R. Subramaniam, B.J. Howard, K. Hensley, M. Aksenova, J.M. Carney, and D.A. Butterfield, "β-Amyloid (32-35) Generates Reactive Free Radicals That Are Toxic to Biomolecules: Implications to Alzheimer's Disease," Alzheimer's Research 1, 141-144 (1995).

130. C.H. Trad, W. James, A. Bhardwaj, and D.A. Butterfield, "Selective Labeling of Membrane Protein Sulfhydryl Groups with Methanethiosulfonate Spin Label," J. Biochem. Biophys. Meth. 30, 287-299 (1995).

129. S. Ganapathi, D.A. Butterfield, and D. Bhattacharyya, "Flat Sheet and Hollow Fiber Membrane Bioreactors: A Study of the Kinetics and Active Site Conformational Changes of Immobilized Papain Including Sorption Studies of Reaction Constituents," J. Chem. Technol. Biotechnol. 64, 157-164 (1995).

128. N.C. Hall, J.M. Carney, M. Cheng, and D.A. Butterfield, "Prevention of Ischemia/Reperfusion-Induced Alterations in Synaptosomal Membrane-Associated Proteins and Lipids by N-tert-butyl-a-phenylnitrone and Difluoromethylornithine," Neuroscience 69, 591-600 (1995).

127. M.E. Harris, J.M. Carney, P. Cole, K. Hensley, B.J. Howard, L. Martin, P. Bummer, Y. Wang, N. Pedigo, and D.A. Butterfield, "β-Amyloid Peptide-Derived, Oxygen-Dependent Free Radicals Inhibit Glutamate Uptake in Cultured Astrocytes: Implications to Alzheimer's Disease," Neuro Report 6, 1875-1879 (1995).

126. K. Hensley, N. Hall, R. Subramaniam, P. Cole, M. Harris, M. Aksenov, M. Aksenova, S.P. Gabbita, J.F. Wu, J.M. Carney, M. Lovell, W.R. Markesbery, and D.A. Butterfield, "Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation," J. Neurochem. 65, 2146-2156 (1995).

125. A. Alvarado, D.A. Butterfield, B.A. Watkins, B.H. Chung, and B. Hennig, " Electron Spin resonance studies of fatty acid-induced alterations in membrane fluidity in cultured endothelial cells," (1995).

124. M.Y. Aksenov, M.V. Aksenova, M.E. Harris, K. Hensley, D.A. Butterfield, and J.M. Carney, "Enhancement of β-Amyloid Peptide Aβ(1–40)-Mediated Neurotoxicity by Glutamine Synthe,"J. Neurochem. 65, 1899-1902 (1995).

123. N.C. Hall, R.J. Dempsey, J.M. Carney, D.L. Donaldson, and D.A. Butterfield, "Structural Alterations in Synaptosomal Membrane-Associated Proteins and Lipids by Transient Middle Cerebral Artery Occulusion in the Cat," Neurochem. Res. 20, 1161-1169 (1995).

122. K. Hensley, D.A. Butterfield, M. Aksenova, M. Harris, J. Wu, R. Floyd, M. Mattson, and J.M. Carney, "A Model for β-Amyloid Aggregation and Neurotoxicity Based on the Free Radical Generating Capacity of the Peptide: Implications of Peptide-Derived Free Radicals to Alzheimer's Disease," Proc. Western Pharmacol. Soc. 38, 113-120 (1995).

121. R.J. Mark, K. Hensley, D.A. Butterfield, and M.P. Mattson, "Amyloid β-Peptide Impairs Ion-Motive ATPase Activities: Evidence for a Role in Loss of Neuronal Ca 2+ Homeostasis and Cell Death," (1995).

120. K. Hensley, B.J. Howard, J.M. Carney, and D.A. Butterfield, "Membrane Protein Alterations in Rodent Erythrocytes and Synaptosomes Due to Aging and Hyperoxia," (1995).

119. M.E. Harris, K. Hensley, D.A. Butterfield, R.A. Leedle, and J.M. Carney, "Direct Evidence of Oxidative Injury Produced by the Alzheimer's Amyloid Beta Peptide (1-40) in Cultured Hippocampal Neurons," (1995).

118. K. Hensley, M. Aksenova, J.M. Carney, M. Harris, and D.A. Butterfield, "Amyloid β-Peptide Spin Trapping II: Evidence for Decomposition of the PBN Spin Adduct," Neuro Report 6, 493-496 (1995).

117. K. Hensley, M. Aksenova, J.M. Carney, M. Harris, and D.A. Butterfield, "Amyloid β-Peptide Spin Trapping I: Peptide Enzyme Toxicity Is Related to Free Radical Spin Trap Reactivity," Neuro Report 6, 489-492 (1995).

116. M.P. Mattson, J.M. Carney, and D.A. Butterfield, "Glycation: A Tombstone in AD?" (1995).

115. N.C. Hall, J.M. Carney, M.S. Cheng, and D.A. Butterfield, "Ischemia/Reperfusion Induced Changes in Membrane Proteins and Lipids of Gerbil Cortical Synaptosomes," (1995).

114. S.S. Bellary, K.W. Anderson, W.A. Arden, and D.A. Butterfield, "Effect of Lipopolysaccharide on the Physical Conformation of the Erythrocyte Cytoskeletal Proteins," (1995).

113. J.M. Carney, C.D. Smith, A.M. Carney, and D.A. Butterfield, "Aging- and Oxygen-Induced Modifications in Brain Biochemistry and Behavior," Annals N.Y. Acad. Sci. 738, 44-53 (1994).

112. D.A. Butterfield, P.J. Shrewsbury, and K. Hensley, "Interaction of HP749 with Erythrocyte and Neocortical Synaptosomal Membranes," Biochemical Archives 10, 285-292 (1994).

111. C.H. Trad and D.A. Butterfield, "Menadione Induced Cytotoxicity Effects on Human Erythrocyte Membranes Studied by Electron Paramagnetic Resonance," Toxicology Letts. 73, 145-155 (1994).

110. K.M. Chan, E.A. Decker, J.B. Lee, and D.A. Butterfield, "ESR Spin-Trapping Studies of the Hydroxyl Radical Scavenging Activity of Carnosine and Related Dipeptides," J. Agric. Food Chem. 42, 1407-1410 (1994).

109. D.A. Butterfield, C.H. Trad, and N.C. Hall, "Effects of Dehydroabietic Acid on the Physical State of Cytoskeletal Proteins and the Lipid Bilayer of Erythrocyte Membranes," Biochim. Biophys. Acta 1192, 185-189 (1994).

108. K. Hensley, J. Carney, N. Hall, W. Shaw, and D.A. Butterfield, "Electron Paramagnetic Resonance Investigations of Free Radical Induced Alterations in Neocortical Synaptosomal Membrane Protein Infrastructure," Free Radical Biol. & Medicine 17, 321-331 (1994).

107. D.A. Butterfield, J. Lee, S. Ganapathi, and D. Bhattacharyya, "Biofunctional Membranes IV. Active Site Structure and Stability of an Immobilized Enzyme, Papain, on Modified Polysulfone Membranes Studied by Electron Paramagnetic Resonance and Kinetics," J. Membrane Sci. 91, 47-64 (1994).

106. D.A. Butterfield and J. Lee, "Active Site Structure and Stability of the Thiol Protease, Papain, Studied by Electron Paramagnetic Resonance Employing a Methanethiosulfonate Spin Label," Arch. Biochem. Biophys. 310, 167-171 (1994).

105. D.A. Butterfield, K. Hensley, M. Harris, M. Mattson, and J. Carney, "β-Amyloid Peptide Free Radical Fragments Initiate Synaptosomal Lipoperoxidation in a Sequence-Specific Fashion: Implications to Alzheimer's Disease," Biochem. Biophys. Res. Commun. 200, 710-715 (1994).

104. K. Hensley, J. Carney, M. Mattson, M. Aksenova, M. Harris, J.F. Wu, R. Floyd, and D.A. Butterfield, "A New Model for β-Amyloid Aggregation and Neurotoxicity Based on Free Radical Generating Capacity of the Peptide: Insights into Alzheimer Disease," Proc. Nat. Acad. Sci. USA 91, 3270-3274 (1994).

103. A. Alvarado, D.A. Butterfield, and B. Hennig, "Disruption of Endothelial Barrier Function: Relationship to Fluidity of Membrane Extracellular Lamella," Int. J. Biochem. 26, 575-581 (1994).

102. D.A. Butterfield, J. Lee, and D. Bhattacharyya, "Biofunctional Membranes: Spin Labeling Comparison of the Active Site Structure of Papain Immobilized on Modified Polysulfone and Modified Cellulose Acetate Membranes," (1994).

101. D.A. Butterfield, B. Sun, S. Bellary, W. Arden, and K.W. Anderson, "Effect of Endotoxin on Lipid Order and Motion in Erythrocyte Membranes," Biochim. Biophys. Acta 1225, 231-234 (1994).

Honors & Awards

HONORS AND AWARDS

Phi Beta Kappa Honorary Society, 1968
Phi Kappa Phi Honorary Society, 1967
NIH Biomedical Science Research Award, 1972
Graduate School Research Award (Duke University), 1972
NIH Postdoctoral Fellowship, 1974
��vlog�ٷ�� Research Foundation Faculty Research Award, 1979
Awarded ��vlog�ٷ�� Research Professorship, 1980 81
Appointed to Biophysics and Biophysical ��vlog�ٷ�� Study Section A of the National Institutes of Health (NIGMS), Spring 1980 Meeting
Appointed to National Institute of Health Site Visit Study Section, Summer 1980
Invited Speaker, Gordon Research Conference on Magnetic Resonance in Biology and Medicine, 1980
Consultant, National Institute on Aging, NIH Site Visit, "Alzheimer's Disease Center," May, 1987
Consultant, National Heart, Lung and Blood Institute, NIH Site Visit, "Comprehensive Sickle Cell Disease Center," May, 1987
Special Faculty Grant, 1988 1990
Editorial Board Member, Journal of Membrane Science, 1989 present
Finalist, College of Arts and Sciences Distinguished Professorship, 1990, 1991
Dow Chemical Distinguished Lectureship, University of D etroit, 1995
The Honorable Order of Kentucky Colonels, 1995
Consultant, National Institute on Aging, NIH Reverse Site Visit on "β-Amyloid Program Project," 1996
Recipient, Distinguished University Scientist Award from the Kentucky Academy of Science, 1996
Consultant, National Science Foundation, Small Business Investigative Research Panel, 1996
Consultant, national Aeronautics and Space Administration, Shuttle Experiment Panel, 1997
Recipient, William B. Sturgill Award for Graduate Education, 1997
Recipient, Southern Chemist Award from the American Chemical Society, Memphis Section, 1997
Recipient, Presidential Award for Excellence in Science, Mathematics and Engineering Mentoring, Presented by President Clinton in the White House , 1998.
Appointed as Senior Associate Editor, Journal of Alzheimer's Disease
Consultant, National Institute on Aging, NIH Site Visit on "Alzheimer's Disease PPG," 1998
Consultant, National Institute on Aging, NIH Site Visit on "Alzheimer's Disease PPG," 1999
Consultant, National Institute on Aging, NIH Site Visit on "Alzheimer's Disease PPG," 2000
Consultant, National Institute on Aging, NIH Site Visit on "Prion Disorders," 2002
Consultant, National Institute on Aging, NIH Site Visit on "Alzheimer's Disease," 2002
Consultant, National Institute on Aging, NIH Site Visit on "Alzheimer's Disease," 2003
Consultant, National Institute on Aging, NIH Site Visit on "Alzheimer's Disease," 2004
Consultant, National Institute on Aging, NIH Site Visit on "Alzheimer's Disease," 2005
Consultant, National Institute on Aging, NIH Site Visit on "Alzheimer's Disease," 2007
Recipient, Honorary Doctor of Science Degree, University of Maine, Commencement, 2002
Alumni Association Endowed Professor of Biological ��vlog�ٷ��, ��vlog�ٷ��, 2002-present
Member, Scientific Advisory Board for Neurobiology, National University of Singapore (One of only 4 international members)
Ad-hoc Member, Study Section on Conflict of Interest, NIGMS, NIH
Ad-hoc Member, Study Section on Synapses, NINDS, NIH
Recipient, Award for Most Outstanding PhD Committee Member for Prince of Songkla University, Thailand, 2007
International Member, Scientific Review Panel, Ministry of Education, for the Government of Singapore, 2006-present
Permanent Member, NIH Study Section on Neural Oxidative and Metabolic Death, 2008-2012
Invited Speaker, Gordon Research Conference on Oxygen Radicals, 2010
Recipient, Albert D. and Elizabeth H. Kirwan Memorial Prize for Excellence in Research, 2010
Member, Editorial Board, Neuroproteomics
Selected as a Fellow of the Society for Free Radical Biology and Medicine, 2012 (one of only 28 Fellows in the world).
Recipient, 2013 Discovery Award from the Society for Free Radical Biology and Medicine
2014: Editorial Board Member, Pharmacological Research
2014: Recipient, Alkmeon International Prize for Progress in Science, presented at the University of Rome, Tor Vergata in Rome, Italy
Member, Editorial Board, Frontiers in Pharmacology
2014: Recipient, Society for Free Radical Biology and Medicine Mentoring Excellence Award
2014: Elected Editorial Board Member, Free Radical Biology and Medicine

����vlog�ٷ����

��vlog�ٷ��